<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <atom:link href="https://feeds.megaphone.fm/gt-the-podcast" rel="self" type="application/rss+xml"/>
    <title>GT: The Podcast</title>
    <language>en</language>
    <copyright>2024 Glaucoma Today </copyright>
    <description>Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.</description>
    <image>
      <url>https://megaphone.imgix.net/podcasts/32faad0c-baf9-11ea-97df-1fb5cbc65e7d/image/uploads_2F1597698321779-2wo17142lj3-5fe151519b997f5b85be1c0708fc4324_2Fgt-podcast-art.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress</url>
      <title>GT: The Podcast</title>
    </image>
    <itunes:explicit>no</itunes:explicit>
    <itunes:type>episodic</itunes:type>
    <itunes:subtitle></itunes:subtitle>
    <itunes:author>Glaucoma Today </itunes:author>
    <itunes:summary>Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.</itunes:summary>
    <content:encoded>
      <![CDATA[<p>Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.</p>]]>
    </content:encoded>
    <itunes:owner>
      <itunes:name>Bryn Mawr Communications</itunes:name>
      <itunes:email>analytics@bmctoday.com</itunes:email>
    </itunes:owner>
    <itunes:image href="https://megaphone.imgix.net/podcasts/32faad0c-baf9-11ea-97df-1fb5cbc65e7d/image/uploads_2F1597698321779-2wo17142lj3-5fe151519b997f5b85be1c0708fc4324_2Fgt-podcast-art.jpg?ixlib=rails-4.3.1&amp;max-w=3000&amp;max-h=3000&amp;fit=crop&amp;auto=format,compress"/>
    <itunes:category text="Technology">
    </itunes:category>
    <itunes:category text="Science">
      <itunes:category text="Life Sciences"/>
    </itunes:category>
    <item>
      <title>Surgical Management of UGH Syndrome</title>
      <description>Glaucoma specialists share insights into treating uveitis-glaucoma-hyphema (UGH) syndrome, as featured in the January/February 2026 issue of Glaucoma Today. Roya Garakani, DO, recaps, “Surgical Decision-Making in Patients With UGH Syndrome,” outlining options for patients with UGH syndrome who require glaucoma surgery in addition to an IOL procedure. Then, Mahsaw Mansoor, MD, recaps, “Selecting an IOL and Fixation Technique for Patients With UGH Syndrome,” which was written with Nicole Fram, MD, and presents a case-based approach to surgical management of in-the-bag UGH syndrome secondary to dead bag syndrome.</description>
      <pubDate>Wed, 15 Apr 2026 16:26:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Glaucoma specialists share insights into treating uveitis-glaucoma-hyphema (UGH) syndrome, as featured in the January/February 2026 issue of Glaucoma Today. Roya Garakani, DO, recaps, “Surgical Decision-Making in Patients With UGH Syndrome,” outlining options for patients with UGH syndrome who require glaucoma surgery in addition to an IOL procedure. Then, Mahsaw Mansoor, MD, recaps, “Selecting an IOL and Fixation Technique for Patients With UGH Syndrome,” which was written with Nicole Fram, MD, and presents a case-based approach to surgical management of in-the-bag UGH syndrome secondary to dead bag syndrome.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Glaucoma specialists share insights into treating uveitis-glaucoma-hyphema (UGH) syndrome, as featured in the January/February 2026 issue of <em>Glaucoma Today</em>. Roya Garakani, DO, recaps, “Surgical Decision-Making in Patients With UGH Syndrome,” outlining options for patients with UGH syndrome who require glaucoma surgery in addition to an IOL procedure. Then, Mahsaw Mansoor, MD, recaps, “Selecting an IOL and Fixation Technique for Patients With UGH Syndrome,” which was written with Nicole Fram, MD, and presents a case-based approach to surgical management of in-the-bag UGH syndrome secondary to dead bag syndrome.</p>]]>
      </content:encoded>
      <itunes:duration>915</itunes:duration>
      <guid isPermaLink="false"><![CDATA[25dce7da-38e7-11f1-b819-1342a43950a5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8890308805.mp3?updated=1776270756" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Reflections on Change</title>
      <description>Welcome to GT: The Podcast! In this episode, glaucoma specialists share the approaches and pearls they wish they had discovered sooner, as featured in the November/December 2025 issue of Glaucoma Today. Kateki Vinod, MD, and Won I. Kim, MD, share their reflections on IOP monitoring and how home tonometry has changed their respective practices. Later, Jenny Lu describes age-related neuroretinal alterations and how these changes can mimic glaucomatous damage, as covered in an article by Shuning Li, MD, PhD, and Ying Han, MD, PhD.</description>
      <pubDate>Wed, 11 Feb 2026 18:46:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Welcome to GT: The Podcast! In this episode, glaucoma specialists share the approaches and pearls they wish they had discovered sooner, as featured in the November/December 2025 issue of Glaucoma Today. Kateki Vinod, MD, and Won I. Kim, MD, share their reflections on IOP monitoring and how home tonometry has changed their respective practices. Later, Jenny Lu describes age-related neuroretinal alterations and how these changes can mimic glaucomatous damage, as covered in an article by Shuning Li, MD, PhD, and Ying Han, MD, PhD.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Welcome to GT: The Podcast! In this episode, glaucoma specialists share the approaches and pearls they wish they had discovered sooner, as featured in the November/December 2025 issue of <em>Glaucoma Today</em>. Kateki Vinod, MD, and Won I. Kim, MD, share their reflections on IOP monitoring and how home tonometry has changed their respective practices. Later, Jenny Lu describes age-related neuroretinal alterations and how these changes can mimic glaucomatous damage, as covered in an article by Shuning Li, MD, PhD, and Ying Han, MD, PhD.</p>]]>
      </content:encoded>
      <itunes:duration>985</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d3a7ba84-0778-11f1-9740-f7a91daa3c78]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3785446847.mp3?updated=1770845410" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>The Paul Glaucoma Implant</title>
      <description>Welcome to GT: The Podcast! In this episode, Chelvin
Sng, BA, MA, MBBChir, MMed, MRCS(Ed), FRCS(Ed), FAMS, recaps her
article, “The Paul Glaucoma Implant,” which was featured in the
November/December issue of Glaucoma Today. The Paul Glaucoma Implant (Advanced Ophthalmic Innovations) is a glaucoma drainage device designed to fulfill the unmet need for a tube shunt with greater efficacy but a lower risk of hypotony. Dr. Sng reviews device characteristics, surgical technique, postoperative
management, and clinical data.</description>
      <pubDate>Tue, 30 Dec 2025 15:55:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Welcome to GT: The Podcast! In this episode, Chelvin
Sng, BA, MA, MBBChir, MMed, MRCS(Ed), FRCS(Ed), FAMS, recaps her
article, “The Paul Glaucoma Implant,” which was featured in the
November/December issue of Glaucoma Today. The Paul Glaucoma Implant (Advanced Ophthalmic Innovations) is a glaucoma drainage device designed to fulfill the unmet need for a tube shunt with greater efficacy but a lower risk of hypotony. Dr. Sng reviews device characteristics, surgical technique, postoperative
management, and clinical data.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Welcome to GT: The Podcast! In this episode, Chelvin
Sng, BA, MA, MBBChir, MMed, MRCS(Ed), FRCS(Ed), FAMS,<strong> </strong>recaps her
article, “The Paul Glaucoma Implant,” which was featured in the
November/December issue of <em>Glaucoma Today</em>. The Paul Glaucoma Implant (Advanced Ophthalmic Innovations) is a glaucoma drainage device designed to fulfill the unmet need for a tube shunt with greater efficacy but a lower risk of hypotony. Dr. Sng reviews device characteristics, surgical technique, postoperative
management, and clinical data.</p>]]>
      </content:encoded>
      <itunes:duration>597</itunes:duration>
      <guid isPermaLink="false"><![CDATA[af900e24-e597-11f0-bdf5-ffd59fb814c2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5917357576.mp3?updated=1767110470" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Glaucoma Intrascleral Tube Surgery</title>
      <description>Welcome to GT: The Podcast! In this episode,
Mohamed M. Khodeiry, MD, MSc, recaps his article, “Glaucoma Intrascleral
Tube Surgery,” written with James Richardson-May, MD, and Ahmed Elbably, MSc, FRCS, and featured in the July/August issue of Glaucoma Today. A surgical modification called glaucoma intrascleral tube surgery (GITS) may help address some postoperative complications associated with subconjunctival stent implantation. Dr. Khodeiry discusses the development of GITS, specifics of the surgical technique, early
outcomes, and future directions.</description>
      <pubDate>Fri, 21 Nov 2025 18:45:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Welcome to GT: The Podcast! In this episode,
Mohamed M. Khodeiry, MD, MSc, recaps his article, “Glaucoma Intrascleral
Tube Surgery,” written with James Richardson-May, MD, and Ahmed Elbably, MSc, FRCS, and featured in the July/August issue of Glaucoma Today. A surgical modification called glaucoma intrascleral tube surgery (GITS) may help address some postoperative complications associated with subconjunctival stent implantation. Dr. Khodeiry discusses the development of GITS, specifics of the surgical technique, early
outcomes, and future directions.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Welcome to GT: The Podcast! In this episode,
Mohamed M. Khodeiry, MD, MSc,<strong> </strong>recaps his article, “Glaucoma Intrascleral
Tube Surgery,” written with James Richardson-May, MD, and Ahmed Elbably, MSc, FRCS, and featured in the July/August issue of <em>Glaucoma Today</em>. A surgical modification called <em>glaucoma intrascleral tube surgery</em> (GITS) may help address some postoperative complications associated with subconjunctival stent implantation. Dr. Khodeiry discusses the development of GITS, specifics of the surgical technique, early
outcomes, and future directions.</p>
<p>




</p>]]>
      </content:encoded>
      <itunes:duration>535</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b8a3540a-c709-11f0-bc6f-bfb26ae010fa]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9860114666.mp3?updated=1763750982" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Tube Erosion</title>
      <description>Rachel Chapman recaps her article, “Tube Erosion,” which was written with Matthew Henderson, MD; Dan Arreaza-Kaufman, MD; Jonathan Eisengart, MD; and Mary Qiu, MD, and was featured in the May/June issue of Glaucoma Today. Glaucoma drainage implants can lower IOP and preserve patients’ vision, but the devices carry the risk of tube erosion, a serious complication that requires prompt surgical management. Ms. Chapman reviews the rates of tube erosion, risk factors, strategies for prevention, and techniques for surgical revision.</description>
      <pubDate>Fri, 24 Oct 2025 21:11:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Rachel Chapman recaps her article, “Tube Erosion,” which was written with Matthew Henderson, MD; Dan Arreaza-Kaufman, MD; Jonathan Eisengart, MD; and Mary Qiu, MD, and was featured in the May/June issue of Glaucoma Today. Glaucoma drainage implants can lower IOP and preserve patients’ vision, but the devices carry the risk of tube erosion, a serious complication that requires prompt surgical management. Ms. Chapman reviews the rates of tube erosion, risk factors, strategies for prevention, and techniques for surgical revision.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Rachel Chapman recaps her article, “Tube Erosion,” which was written with Matthew Henderson, MD; Dan Arreaza-Kaufman, MD; Jonathan Eisengart, MD; and Mary Qiu, MD, and was featured in the May/June issue of <em>Glaucoma Today</em>. Glaucoma drainage implants can lower IOP and preserve patients’ vision, but the devices carry the risk of tube erosion, a serious complication that requires prompt surgical management. Ms. Chapman reviews the rates of tube erosion, risk factors, strategies for prevention, and techniques for surgical revision.</p>]]>
      </content:encoded>
      <itunes:duration>629</itunes:duration>
      <guid isPermaLink="false"><![CDATA[cd5daf6e-b11d-11f0-b29c-473c8af88d22]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8320066976.mp3?updated=1763500053" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Reducing Medication Burden for an Unhappy Patient</title>
      <description>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Emily Schehlein, MD, and H. George Tanaka, MD, to review a real case from his practice involving a patient with glaucoma with a history of SLT and MIGS. Though the patient’s IOP is at target, she is very unhappy with topical medication. The group discusses the importance of quality of life and weighs possible next steps, including drug delivery, repeat SLT, surgical intervention, or continuing as is. Later, the guests find out what Dr. Singh did, and they compare their opinions with the results of a social media poll of GT’s audience.</description>
      <pubDate>Thu, 02 Oct 2025 13:32:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Emily Schehlein, MD, and H. George Tanaka, MD, to review a real case from his practice involving a patient with glaucoma with a history of SLT and MIGS. Though the patient’s IOP is at target, she is very unhappy with topical medication. The group discusses the importance of quality of life and weighs possible next steps, including drug delivery, repeat SLT, surgical intervention, or continuing as is. Later, the guests find out what Dr. Singh did, and they compare their opinions with the results of a social media poll of GT’s audience.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of Survey Says, a special edition of <em>GT: The Podcast</em>, I. Paul Singh, MD, is joined by guests Emily Schehlein, MD, and H. George Tanaka, MD, to review a real case from his practice involving a patient with glaucoma with a history of SLT and MIGS. Though the patient’s IOP is at target, she is very unhappy with topical medication. The group discusses the importance of quality of life and weighs possible next steps, including drug delivery, repeat SLT, surgical intervention, or continuing as is. Later, the guests find out what Dr. Singh did, and they compare their opinions with the results of a social media poll of <em>GT</em>’s audience.</p>]]>
      </content:encoded>
      <itunes:duration>2304</itunes:duration>
      <guid isPermaLink="false"><![CDATA[de3f59c2-9f93-11f0-ac65-33ab1c8e28dd]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5326141919.mp3?updated=1759412225" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>The Role of Anterior Segment OCT in MIGS</title>
      <description>Neeru A. Vallabh, MBBS, FRCOphth, PhD, FEBOS-GL, recaps her article, “The Role of Anterior Segment OCT in MIGS,” which was featured in the March/April issue of Glaucoma Today. Dr. Vallabh explores how this mode of advanced imaging can enhance the patient evaluation and surgical results, reviewing its utility for preoperative evaluation and intraoperative adjustments and its ability to provide insights into postoperative outcomes.</description>
      <pubDate>Fri, 22 Aug 2025 15:00:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Neeru A. Vallabh, MBBS, FRCOphth, PhD, FEBOS-GL, recaps her article, “The Role of Anterior Segment OCT in MIGS,” which was featured in the March/April issue of Glaucoma Today. Dr. Vallabh explores how this mode of advanced imaging can enhance the patient evaluation and surgical results, reviewing its utility for preoperative evaluation and intraoperative adjustments and its ability to provide insights into postoperative outcomes.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Neeru A. Vallabh, MBBS, FRCOphth, PhD, FEBOS-GL, recaps her article, “The Role of Anterior Segment OCT in MIGS,” which was featured in the March/April issue of <em>Glaucoma Today</em>. Dr. Vallabh explores how this mode of advanced imaging can enhance the patient evaluation and surgical results, reviewing its utility for preoperative evaluation and intraoperative adjustments and its ability to provide insights into postoperative outcomes.</p>]]>
      </content:encoded>
      <itunes:duration>530</itunes:duration>
      <guid isPermaLink="false"><![CDATA[27b9f9d2-7f68-11f0-9763-0b26dd8ed9a5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8227230492.mp3?updated=1755875089" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Sustained Drug Delivery in Interventional Glaucoma</title>
      <description>I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. 



Editorially independent content supported with advertising by Glaukos. </description>
      <pubDate>Fri, 15 Aug 2025 13:00:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. 



Editorially independent content supported with advertising by Glaukos. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. </p>
<p><br></p>
<p>Editorially independent content supported with advertising by Glaukos. </p>]]>
      </content:encoded>
      <itunes:duration>2282</itunes:duration>
      <guid isPermaLink="false"><![CDATA[0a33c0de-794e-11f0-9af4-dbcaf6625ce3]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7876225213.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>A Cilioscleral Interpositioning Device</title>
      <description>Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS, recaps his article, “A Cilioscleral Interpositioning Device,” which was featured in the March/April issue of Glaucoma Today and explores a novel class of glaucoma surgery that targets the supraciliary space. The Intercil Uveal Spacer from Ciliatech represents this new class of surgical implants known as cilioscleral interpositioning devices, or CIDs, which enhance uveoscleral outflow to lower IOP.</description>
      <pubDate>Mon, 28 Jul 2025 15:02:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS, recaps his article, “A Cilioscleral Interpositioning Device,” which was featured in the March/April issue of Glaucoma Today and explores a novel class of glaucoma surgery that targets the supraciliary space. The Intercil Uveal Spacer from Ciliatech represents this new class of surgical implants known as cilioscleral interpositioning devices, or CIDs, which enhance uveoscleral outflow to lower IOP.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS, recaps his article, “A Cilioscleral Interpositioning Device,” which was featured in the March/April issue of <em>Glaucoma Today</em> and explores a novel class of glaucoma surgery that targets the supraciliary space. The Intercil Uveal Spacer from Ciliatech represents this new class of surgical implants known as cilioscleral interpositioning devices, or CIDs, which enhance uveoscleral outflow to lower IOP.</p>]]>
      </content:encoded>
      <itunes:duration>522</itunes:duration>
      <guid isPermaLink="false"><![CDATA[879e8d8a-6bc3-11f0-b02b-236b0f3e7adc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4318962597.mp3?updated=1753715238" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Choosing Treatment for a High-Risk Patient</title>
      <description>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of GT’s audience and find out what Dr. Singh did.</description>
      <pubDate>Thu, 26 Jun 2025 20:34:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of GT’s audience and find out what Dr. Singh did.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of Survey Says, a special edition of <em>GT: The Podcast</em>, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of <em>GT</em>’s audience and find out what Dr. Singh did.</p>]]>
      </content:encoded>
      <itunes:duration>2105</itunes:duration>
      <guid isPermaLink="false"><![CDATA[bb40f2b4-52cc-11f0-b69c-3b6ef12b7c88]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2241764993.mp3?updated=1750970406" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Career Change: Making the Vision Come to Life • Private Practice Versus Academia </title>
      <description>In this episode, two Glaucoma Today contributors dive into the topic of career paths in ophthalmology, comparing different options and offering pearls from their own experiences. Zahra Ali, MD, recaps her article, “Career Change: Making the Vision Come to Life,” which chronicles her personal transition from general ophthalmologist to glaucoma specialist. Then, Devang L. Bhoiwala, MD, recaps his article, “Private Practice Versus Academia,” which outlines the pros and cons of these two distinct career paths.</description>
      <pubDate>Fri, 23 May 2025 18:08:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode, two Glaucoma Today contributors dive into the topic of career paths in ophthalmology, comparing different options and offering pearls from their own experiences. Zahra Ali, MD, recaps her article, “Career Change: Making the Vision Come to Life,” which chronicles her personal transition from general ophthalmologist to glaucoma specialist. Then, Devang L. Bhoiwala, MD, recaps his article, “Private Practice Versus Academia,” which outlines the pros and cons of these two distinct career paths.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode, two <em>Glaucoma Today</em> contributors dive into the topic of career paths in ophthalmology, comparing different options and offering pearls from their own experiences. Zahra Ali, MD, recaps her article, “Career Change: Making the Vision Come to Life,” which chronicles her personal transition from general ophthalmologist to glaucoma specialist. Then, Devang L. Bhoiwala, MD, recaps his article, “Private Practice Versus Academia,” which outlines the pros and cons of these two distinct career paths.</p>]]>
      </content:encoded>
      <itunes:duration>916</itunes:duration>
      <guid isPermaLink="false"><![CDATA[65f92c40-3800-11f0-a3f9-63b8530f141f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3975982459.mp3?updated=1748024001" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Metabolic Dysfunction in Glaucoma</title>
      <description>Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of Glaucoma Today. IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.</description>
      <pubDate>Mon, 28 Apr 2025 01:06:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of Glaucoma Today. IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of <em>Glaucoma Today.</em> IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.</p>]]>
      </content:encoded>
      <itunes:duration>1751</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b630eb28-23cc-11f0-bdf1-cb54ba632985]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5505240656.mp3?updated=1745802706" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Proceeding After Unsuccessful Treatment</title>
      <description>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Manjool Shah, MD, and Ticiana De Francesco, MD, to review a real case from his practice. They discuss the patient’s treatment history and how it informs which procedures to consider for the future and which ones to rule out. The guests share how they would proceed before finding out what Dr. Singh did and how their colleagues would approach the case, based on results of a social media poll of GT’s audience.</description>
      <pubDate>Wed, 19 Mar 2025 17:46:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Manjool Shah, MD, and Ticiana De Francesco, MD, to review a real case from his practice. They discuss the patient’s treatment history and how it informs which procedures to consider for the future and which ones to rule out. The guests share how they would proceed before finding out what Dr. Singh did and how their colleagues would approach the case, based on results of a social media poll of GT’s audience.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of Survey Says, a special edition of <em>GT: The Podcast</em>, I. Paul Singh, MD, is joined by guests Manjool Shah, MD, and Ticiana De Francesco, MD, to review a real case from his practice. They discuss the patient’s treatment history and how it informs which procedures to consider for the future and which ones to rule out. The guests share how they would proceed before finding out what Dr. Singh did and how their colleagues would approach the case, based on results of a social media poll of <em>GT</em>’s audience.</p>]]>
      </content:encoded>
      <itunes:duration>1562</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7a1fdf6a-04e9-11f0-98fe-83750379a666]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1231986228.mp3?updated=1742406691" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation</title>
      <description>Catherine Johnson, MD, MPH, recaps her article, “Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation,” which was written with Barbara Wirostko, MD, FARVO, and featured in the November/December issue of Glaucoma Today. Home tonometry data are shedding light on SLT’s effect on IOP spikes in the months following laser treatment. This article reviews diurnal IOP fluctuation before and after SLT and discusses the implications of home tonometry in research.</description>
      <pubDate>Mon, 24 Feb 2025 16:55:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Catherine Johnson, MD, MPH, recaps her article, “Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation,” which was written with Barbara Wirostko, MD, FARVO, and featured in the November/December issue of Glaucoma Today. Home tonometry data are shedding light on SLT’s effect on IOP spikes in the months following laser treatment. This article reviews diurnal IOP fluctuation before and after SLT and discusses the implications of home tonometry in research.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Catherine Johnson, MD, MPH, recaps her article, “Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation,” which was written with Barbara Wirostko, MD, FARVO, and featured in the November/December issue of <em>Glaucoma Today</em>. Home tonometry data are shedding light on SLT’s effect on IOP spikes in the months following laser treatment. This article reviews diurnal IOP fluctuation before and after SLT and discusses the implications of home tonometry in research.</p>]]>
      </content:encoded>
      <itunes:duration>478</itunes:duration>
      <guid isPermaLink="false"><![CDATA[29b0b77e-f2cf-11ef-abf7-db18d7a9b1c9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL6189739869.mp3?updated=1740416418" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye</title>
      <description>N. Troy Gurney, MD, and Richard K. Lee, MD, PhD, recap their article, “Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye,” which was featured in a recent issue of Glaucoma Today. They make the case that transscleral cyclophotocoagulation should be considered earlier in the glaucoma treatment algorithm and review the proper technique and indications to maximize effectiveness and minimize complications.</description>
      <pubDate>Wed, 29 Jan 2025 19:28:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>N. Troy Gurney, MD, and Richard K. Lee, MD, PhD, recap their article, “Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye,” which was featured in a recent issue of Glaucoma Today. They make the case that transscleral cyclophotocoagulation should be considered earlier in the glaucoma treatment algorithm and review the proper technique and indications to maximize effectiveness and minimize complications.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>N. Troy Gurney, MD, and Richard K. Lee, MD, PhD, recap their article, “Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye,” which was featured in a recent issue of <em>Glaucoma Today</em>. They make the case that transscleral cyclophotocoagulation should be considered earlier in the glaucoma treatment algorithm and review the proper technique and indications to maximize effectiveness and minimize complications.</p>]]>
      </content:encoded>
      <itunes:duration>784</itunes:duration>
      <guid isPermaLink="false"><![CDATA[a0d1a164-de76-11ef-bf78-9b854d0640c5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9282401034.mp3?updated=1738179244" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Treatment for a High-Risk Patient</title>
      <description>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while still leaving options on the table for future treatment. Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience.</description>
      <pubDate>Thu, 19 Dec 2024 19:37:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while still leaving options on the table for future treatment. Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while still leaving options on the table for future treatment. Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of <em>GT</em>’s audience.</p>]]>
      </content:encoded>
      <itunes:duration>2201</itunes:duration>
      <guid isPermaLink="false"><![CDATA[084c9954-be40-11ef-b1af-0b7282d5d0c5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8134760140.mp3?updated=1734705933" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Chronic Stress and Glaucomatous Progression • Advances in Eye Drop Aids</title>
      <description>This episode features two articles recently published in Glaucoma Today. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick Chak, MD, and makes the case that it may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters. Then, Mona Kaleem, MD, recaps her article—“Advances in Eye Drop Aids”—which was written with Delcora Huggins, BS, and reviews four available solutions to help overcome the challenges associated with eye drop administration.</description>
      <pubDate>Mon, 25 Nov 2024 14:11:11 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>This episode features two articles recently published in Glaucoma Today. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick Chak, MD, and makes the case that it may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters. Then, Mona Kaleem, MD, recaps her article—“Advances in Eye Drop Aids”—which was written with Delcora Huggins, BS, and reviews four available solutions to help overcome the challenges associated with eye drop administration.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>This episode features two articles recently published in <em>Glaucoma Today</em>. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick Chak, MD, and makes the case that it may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters. Then, Mona Kaleem, MD, recaps her article—“Advances in Eye Drop Aids”—which was written with Delcora Huggins, BS, and reviews four available solutions to help overcome the challenges associated with eye drop administration.</p>]]>
      </content:encoded>
      <itunes:duration>986</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b5a321da-ab36-11ef-8a1c-9bc06bcaa114]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5754799767.mp3?updated=1732544214" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Improving the Affordability of Glaucoma Medications</title>
      <description>Jason Xiao, BS, recaps his article, “Improving the Affordability of Glaucoma Medications,” which was written with Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD, and featured in the May/June issue of Glaucoma Today. Their article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients’ out-of-pocket pharmacy costs.</description>
      <pubDate>Fri, 25 Oct 2024 16:10:04 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Jason Xiao, BS, recaps his article, “Improving the Affordability of Glaucoma Medications,” which was written with Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD, and featured in the May/June issue of Glaucoma Today. Their article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients’ out-of-pocket pharmacy costs.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Jason Xiao, BS, recaps his article, “Improving the Affordability of Glaucoma Medications,” which was written with Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD, and featured in the May/June issue of <em>Glaucoma Today</em>. Their article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients’ out-of-pocket pharmacy costs.</p>]]>
      </content:encoded>
      <itunes:duration>510</itunes:duration>
      <guid isPermaLink="false"><![CDATA[993c0074-92eb-11ef-ba75-c346376b14d5]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2707700905.mp3?updated=1729872906" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Initial Visits and Long-term Care of Glaucoma Patients in Primary Eye Care Settings</title>
      <description>Which technologies are essential to conducting a thorough examination for new glaucoma patients? And which modalities and softwares are most useful for long-term care? Danica Marrelli, OD, and Anu Laul, OD, compare their approaches to initial encounters with glaucoma patients, swap notes on their preferred methodologies for tracking long-term treatment, and identify areas where primary eye care providers could improve the quality of care.</description>
      <pubDate>Wed, 16 Oct 2024 12:12:03 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Which technologies are essential to conducting a thorough examination for new glaucoma patients? And which modalities and softwares are most useful for long-term care? Danica Marrelli, OD, and Anu Laul, OD, compare their approaches to initial encounters with glaucoma patients, swap notes on their preferred methodologies for tracking long-term treatment, and identify areas where primary eye care providers could improve the quality of care.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Which technologies are essential to conducting a thorough examination for new glaucoma patients? And which modalities and softwares are most useful for long-term care? Danica Marrelli, OD, and Anu Laul, OD, compare their approaches to initial encounters with glaucoma patients, swap notes on their preferred methodologies for tracking long-term treatment, and identify areas where primary eye care providers could improve the quality of care.</p>]]>
      </content:encoded>
      <itunes:duration>1083</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d4dc5f38-8bb7-11ef-bb1c-174128f9b72d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2769475142.mp3?updated=1729081014" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Next Steps for Slowly Progressive Disease</title>
      <description>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Monica Ertel, MD, and Mark Gallardo, MD, to review a case from Dr. Singh’s practice. The guests share their perspective on a patient with slowly progressive disease and a history of failed trabeculectomy, and they offer their thoughts on IOP goals and potential treatments. Later, the panelists find out how their colleagues would approach the case based on results of a social media poll of GT’s audience.</description>
      <pubDate>Thu, 19 Sep 2024 20:30:38 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Monica Ertel, MD, and Mark Gallardo, MD, to review a case from Dr. Singh’s practice. The guests share their perspective on a patient with slowly progressive disease and a history of failed trabeculectomy, and they offer their thoughts on IOP goals and potential treatments. Later, the panelists find out how their colleagues would approach the case based on results of a social media poll of GT’s audience.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Monica Ertel, MD, and Mark Gallardo, MD, to review a case from Dr. Singh’s practice. The guests share their perspective on a patient with slowly progressive disease and a history of failed trabeculectomy, and they offer their thoughts on IOP goals and potential treatments. Later, the panelists find out how their colleagues would approach the case based on results of a social media poll of <em>GT</em>’s audience.</p>]]>
      </content:encoded>
      <itunes:duration>2268</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fae208ee-76c3-11ef-96eb-2bddcc3d4ee0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1649209401.mp3?updated=1726778118" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Masqueraders of Normal-Tension Glaucoma</title>
      <description>Jay Patel, MD, recaps his article, “Masqueraders of Normal-Tension Glaucoma,” coauthored with Amanda D. Henderson, MD, and featured in the May/June issue of Glaucoma Today. The article outlines several types of nonglaucomatous optic neuropathy that should be considered in patients with gradually progressive optic neuropathy.</description>
      <pubDate>Fri, 23 Aug 2024 16:38:15 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Jay Patel, MD, recaps his article, “Masqueraders of Normal-Tension Glaucoma,” coauthored with Amanda D. Henderson, MD, and featured in the May/June issue of Glaucoma Today. The article outlines several types of nonglaucomatous optic neuropathy that should be considered in patients with gradually progressive optic neuropathy.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Jay Patel, MD, recaps his article, “Masqueraders of Normal-Tension Glaucoma,” coauthored with Amanda D. Henderson, MD, and featured in the May/June issue of <em>Glaucoma Today</em>. The article outlines several types of nonglaucomatous optic neuropathy that should be considered in patients with gradually progressive optic neuropathy.</p>]]>
      </content:encoded>
      <itunes:duration>658</itunes:duration>
      <guid isPermaLink="false"><![CDATA[3c4e171c-616d-11ef-ae2a-77a3bac90bcc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9705941081.mp3?updated=1724431317" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>DARC: From Bench to Bedside</title>
      <description>Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.</description>
      <pubDate>Mon, 22 Jul 2024 19:37:49 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of <em>Glaucoma Today</em>. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.</p>]]>
      </content:encoded>
      <itunes:duration>1393</itunes:duration>
      <guid isPermaLink="false"><![CDATA[7bcab94c-4861-11ef-84bc-375099e4d2e8]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1566047378.mp3?updated=1721677292" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Is Glaucoma Policy Short-Sighted?</title>
      <description>David Solá-Del Valle, MD, recaps his article—“Is Glaucoma Policy Short-Sighted?”—which was written with Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; and Henisk Falah, BS, and featured in the March/April issue of Glaucoma Today. In their article, the authors discuss the shortfalls of health care policies that guide glaucoma care and propose redefining innovation to keep an eye on patient access.</description>
      <pubDate>Mon, 24 Jun 2024 20:53:13 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>David Solá-Del Valle, MD, recaps his article—“Is Glaucoma Policy Short-Sighted?”—which was written with Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; and Henisk Falah, BS, and featured in the March/April issue of Glaucoma Today. In their article, the authors discuss the shortfalls of health care policies that guide glaucoma care and propose redefining innovation to keep an eye on patient access.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>David Solá-Del Valle, MD, recaps his article—“Is Glaucoma Policy Short-Sighted?”—which was written with Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; and Henisk Falah, BS, and featured in the March/April issue of <em>Glaucoma Today</em>. In their article, the authors discuss the shortfalls of health care policies that guide glaucoma care and propose redefining innovation to keep an eye on patient access.</p>]]>
      </content:encoded>
      <itunes:duration>1022</itunes:duration>
      <guid isPermaLink="false"><![CDATA[adb123f8-326b-11ef-9301-3f4ded4ac94b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1910718127.mp3?updated=1719262710" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Back to Basics: Patient Encounters in Glaucoma </title>
      <description>Slow down, take a breath, and get back to basics with glaucoma care. Join moderator I. Paul Singh, MD, and panelists Sarah Van Tassel, MD, and Joseph Panarelli, MD, as they review their priorities for their patient encounters in Glaucoma. Which imaging modalities are most effective? How do their workflows function? And, as new patients become returning patients, how can software solutions such as the ZEISS Glaucoma Workplace help keep your clinic flowing smoothly?</description>
      <pubDate>Wed, 05 Jun 2024 04:01:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Slow down, take a breath, and get back to basics with glaucoma care. Join moderator I. Paul Singh, MD, and panelists Sarah Van Tassel, MD, and Joseph Panarelli, MD, as they review their priorities for their patient encounters in Glaucoma. Which imaging modalities are most effective? How do their workflows function? And, as new patients become returning patients, how can software solutions such as the ZEISS Glaucoma Workplace help keep your clinic flowing smoothly?</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Slow down, take a breath, and get back to basics with glaucoma care. Join moderator I. Paul Singh, MD, and panelists Sarah Van Tassel, MD, and Joseph Panarelli, MD, as they review their priorities for their patient encounters in Glaucoma. Which imaging modalities are most effective? How do their workflows function? And, as new patients become returning patients, how can software solutions such as the ZEISS Glaucoma Workplace help keep your clinic flowing smoothly?</p>]]>
      </content:encoded>
      <itunes:duration>1378</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b00d9036-228b-11ef-bb74-e7217475fd1d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2817368268.mp3?updated=1717596155" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Clinical Experiences With the Hydrus Microstent</title>
      <description>In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement.</description>
      <pubDate>Wed, 29 May 2024 18:40:10 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement.</p>]]>
      </content:encoded>
      <itunes:duration>2364</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6462f034-08ac-11ef-8877-9bb7d263fc93]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2087437958.mp3?updated=1717008332" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Fluctuating IOP and Poor Compliance</title>
      <description>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Jella An, MD, MBA, and John Berdahl, MD. Dr. Singh presents a real patient case from his practice, and the guests share their initial reactions to the case, what they would do next, and what their goals would be for the patient. Later the guests find out how their colleagues would approach the case based on results of a social media poll of GT’s audience.</description>
      <pubDate>Tue, 28 May 2024 13:53:42 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Jella An, MD, MBA, and John Berdahl, MD. Dr. Singh presents a real patient case from his practice, and the guests share their initial reactions to the case, what they would do next, and what their goals would be for the patient. Later the guests find out how their colleagues would approach the case based on results of a social media poll of GT’s audience.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Jella An, MD, MBA, and John Berdahl, MD. Dr. Singh presents a real patient case from his practice, and the guests share their initial reactions to the case, what they would do next, and what their goals would be for the patient. Later the guests find out how their colleagues would approach the case based on results of a social media poll of <em>GT’s</em> audience.</p>]]>
      </content:encoded>
      <itunes:duration>2377</itunes:duration>
      <guid isPermaLink="false"><![CDATA[afc4661a-1cf8-11ef-80c2-b35f03ca14fd]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9720417743.mp3?updated=1716904569" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Establishing a Glaucoma Practice Fresh Out of Fellowship</title>
      <description>Emily Schehlein, MD, recaps her article, “Establishing a Glaucoma Practice Fresh Out of Fellowship,” which was featured in the March/April issue of Glaucoma Today. When ophthalmology training ends, the work of building a practice officially begins. In her article, Dr. Schehlein, a glaucoma specialist at Brighton Vision Center in Brighton, Michigan, offers insights and strategies for young ophthalmologists in building a successful, specialized practice.</description>
      <pubDate>Mon, 22 Apr 2024 14:27:51 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Emily Schehlein, MD, recaps her article, “Establishing a Glaucoma Practice Fresh Out of Fellowship,” which was featured in the March/April issue of Glaucoma Today. When ophthalmology training ends, the work of building a practice officially begins. In her article, Dr. Schehlein, a glaucoma specialist at Brighton Vision Center in Brighton, Michigan, offers insights and strategies for young ophthalmologists in building a successful, specialized practice.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Emily Schehlein, MD, recaps her article, “Establishing a Glaucoma Practice Fresh Out of Fellowship,” which was featured in the March/April issue of <em>Glaucoma Today</em>. When ophthalmology training ends, the work of building a practice officially begins. In her article, Dr. Schehlein, a glaucoma specialist at Brighton Vision Center in Brighton, Michigan, offers insights and strategies for young ophthalmologists in building a successful, specialized practice.</p>]]>
      </content:encoded>
      <itunes:duration>558</itunes:duration>
      <guid isPermaLink="false"><![CDATA[21a9ac10-00b4-11ef-869f-4f388c8eab0f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL6003057574.mp3?updated=1713796214" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Learning and Teaching MIGS</title>
      <description>Jessie Wang, MD, and Mary Qiu, MD, recap their article, “Learning and Teaching MIGS,” which was featured in the November/December issue of Glaucoma Today. With the growing prevalence of MIGS, it has become increasingly vital for graduating ophthalmologists to be comfortable performing this class of surgeries. In this article, Drs. Wang and Qiu offer their perspectives as a senior resident learning MIGS and an attending surgeon teaching it, respectively.</description>
      <pubDate>Fri, 23 Feb 2024 14:03:53 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Jessie Wang, MD, and Mary Qiu, MD, recap their article, “Learning and Teaching MIGS,” which was featured in the November/December issue of Glaucoma Today. With the growing prevalence of MIGS, it has become increasingly vital for graduating ophthalmologists to be comfortable performing this class of surgeries. In this article, Drs. Wang and Qiu offer their perspectives as a senior resident learning MIGS and an attending surgeon teaching it, respectively.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Jessie Wang, MD, and Mary Qiu, MD, recap their article, “Learning and Teaching MIGS,” which was featured in the November/December issue of <em>Glaucoma Today</em>. With the growing prevalence of MIGS, it has become increasingly vital for graduating ophthalmologists to be comfortable performing this class of surgeries. In this article, Drs. Wang and Qiu offer their perspectives as a senior resident learning MIGS and an attending surgeon teaching it, respectively.</p>]]>
      </content:encoded>
      <itunes:duration>498</itunes:duration>
      <guid isPermaLink="false"><![CDATA[e96da9e8-d253-11ee-82ef-9366c77b8174]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3971397411.mp3?updated=1708697135" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Which Treatment Next?</title>
      <description>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Zarmeena Vendal, MD, and Joseph F. Panarelli, MD. They share their perspectives on how glaucoma care has evolved in recent decades and how these changes have affected their decision-making process. Later, the guests weigh in on the case at hand, sharing their preferred treatment options for the patient. Then, they review how their colleagues would proceed, based on results of a social media poll of GT’s audience.</description>
      <pubDate>Thu, 18 Jan 2024 21:49:28 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Zarmeena Vendal, MD, and Joseph F. Panarelli, MD. They share their perspectives on how glaucoma care has evolved in recent decades and how these changes have affected their decision-making process. Later, the guests weigh in on the case at hand, sharing their preferred treatment options for the patient. Then, they review how their colleagues would proceed, based on results of a social media poll of GT’s audience.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests<em> </em>Zarmeena Vendal, MD, and Joseph F. Panarelli, MD. They share their perspectives on how glaucoma care has evolved in recent decades and how these changes have affected their decision-making process.<em> </em>Later, the guests weigh in on the case at hand, sharing their preferred treatment options for the patient. Then, they review how their colleagues would proceed, based on results of a social media poll of <em>GT’s </em>audience.</p>]]>
      </content:encoded>
      <itunes:duration>2726</itunes:duration>
      <guid isPermaLink="false"><![CDATA[6e57fa08-b64a-11ee-8145-030899079108]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1826797486.mp3?updated=1705614832" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Clinical Experiences With the Hydrus Microstent</title>
      <description>In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement.</description>
      <pubDate>Thu, 28 Dec 2023 14:08:39 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement.</p>]]>
      </content:encoded>
      <itunes:duration>2607</itunes:duration>
      <guid isPermaLink="false"><![CDATA[9cda874a-a58a-11ee-a123-f733407a916e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7416807551.mp3?updated=1703772826" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Management of Tube Erosion</title>
      <description>Shivani Kamat, MD, recaps her article, “Management of Tube Erosion,” which was featured in the September/October issue of Glaucoma Today. Tube erosion through the conjunctiva is a complication of glaucoma drainage device implantation that carries the potential risks of infection and vision loss. Dr. Kamat’s article reviews this complication, including its proper identification and treatment to prevent recurrence and infection.</description>
      <pubDate>Wed, 29 Nov 2023 14:39:34 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Shivani Kamat, MD, recaps her article, “Management of Tube Erosion,” which was featured in the September/October issue of Glaucoma Today. Tube erosion through the conjunctiva is a complication of glaucoma drainage device implantation that carries the potential risks of infection and vision loss. Dr. Kamat’s article reviews this complication, including its proper identification and treatment to prevent recurrence and infection.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Shivani Kamat, MD, recaps her article, “Management of Tube Erosion,” which was featured in the September/October issue of <em>Glaucoma Today</em>. Tube erosion through the conjunctiva is a complication of glaucoma drainage device implantation that carries the potential risks of infection and vision loss. Dr. Kamat’s article reviews this complication, including its proper identification and treatment to prevent recurrence and infection.</p>]]>
      </content:encoded>
      <itunes:duration>685</itunes:duration>
      <guid isPermaLink="false"><![CDATA[ff79567e-8ec4-11ee-943c-e366961dba19]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9627914818.mp3?updated=1701269025" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Geographic Atrophy: A New Treatment Paradigm </title>
      <description>Nathan M. Radcliffe, MD, moderates a discussion with Deborah Ristvedt, DO, and John Kitchens, MD, about the future of geographic atrophy (GA) treatment and management, the history of GA care, considerations for managing cataracts and glaucoma, and more. </description>
      <pubDate>Fri, 10 Nov 2023 05:01:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Nathan M. Radcliffe, MD, moderates a discussion with Deborah Ristvedt, DO, and John Kitchens, MD, about the future of geographic atrophy (GA) treatment and management, the history of GA care, considerations for managing cataracts and glaucoma, and more. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Nathan M. Radcliffe, MD, moderates a discussion with Deborah Ristvedt, DO, and John Kitchens, MD, about the future of geographic atrophy (GA) treatment and management, the history of GA care, considerations for managing cataracts and glaucoma, and more. </p>]]>
      </content:encoded>
      <itunes:duration>2021</itunes:duration>
      <guid isPermaLink="false"><![CDATA[bb585122-7f54-11ee-a27e-e7e044732495]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3253651385.mp3?updated=1699652955" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Patient Experience Data Collection</title>
      <description>Section Editor Richie Kahn, MPH, recaps his article—“Patient Experience Data Collection”—which was written with Jenn McNary and recently featured in GT. The article covers what patient experience data is and how the information can provide regulatory authorities, payers, providers, and patient communities with a more holistic view of a therapy’s impact. </description>
      <pubDate>Tue, 24 Oct 2023 14:14:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Section Editor Richie Kahn, MPH, recaps his article—“Patient Experience Data Collection”—which was written with Jenn McNary and recently featured in GT. The article covers what patient experience data is and how the information can provide regulatory authorities, payers, providers, and patient communities with a more holistic view of a therapy’s impact. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Section Editor Richie Kahn, MPH, recaps his article—“Patient Experience Data Collection”—which was written with Jenn McNary and recently featured in <em>GT</em>. The article covers what patient experience data is and how the information can provide regulatory authorities, payers, providers, and patient communities with a more holistic view of a therapy’s impact. </p>]]>
      </content:encoded>
      <itunes:duration>496</itunes:duration>
      <guid isPermaLink="false"><![CDATA[88419e5e-7277-11ee-9ad2-a71705a59f7b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1558634241.mp3?updated=1698177453" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Prioritizing Processes Over Goals</title>
      <description>Matt Schlenker, MD, MSc, recaps his article, “Prioritizing Processes Over Goals,” which was featured in the May/June issue of Glaucoma Today. In this article, Dr. Schlenker makes the argument that results have more to do with the systems we follow as opposed to the goals we set. He explains the limits of goal setting and delves into the importance of habit forming as a way to achieve real progress in surgery and surgical training.</description>
      <pubDate>Mon, 25 Sep 2023 21:50:41 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Matt Schlenker, MD, MSc, recaps his article, “Prioritizing Processes Over Goals,” which was featured in the May/June issue of Glaucoma Today. In this article, Dr. Schlenker makes the argument that results have more to do with the systems we follow as opposed to the goals we set. He explains the limits of goal setting and delves into the importance of habit forming as a way to achieve real progress in surgery and surgical training.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Matt Schlenker, MD, MSc, recaps his article, “Prioritizing Processes Over Goals,” which was featured in the May/June issue of <em>Glaucoma Today</em>. In this article, Dr. Schlenker makes the argument that results have more to do with the systems we follow as opposed to the goals we set. He explains the limits of goal setting and delves into the importance of habit forming as a way to achieve real progress in surgery and surgical training.</p>]]>
      </content:encoded>
      <itunes:duration>521</itunes:duration>
      <guid isPermaLink="false"><![CDATA[3128f9b4-5bed-11ee-b572-bbed63fe85bd]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2046536547.mp3?updated=1695678779" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Target IOP and Next Steps</title>
      <description>On this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Oluwatosin Smith, MD, and Jason Bacharach, MD. The panel delves into the benefits and challenges of having a wide array of treatment options for glaucoma and how they approach decisions about surgical intervention. Later, they weigh in on the case in question, offering their thoughts on the target IOP and treatment goals for a patient with moderate primary open-angle glaucoma. Then, they review how their colleagues would proceed based on results of a social media poll of Glaucoma Today’s audience.</description>
      <pubDate>Thu, 24 Aug 2023 15:41:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Oluwatosin Smith, MD, and Jason Bacharach, MD. The panel delves into the benefits and challenges of having a wide array of treatment options for glaucoma and how they approach decisions about surgical intervention. Later, they weigh in on the case in question, offering their thoughts on the target IOP and treatment goals for a patient with moderate primary open-angle glaucoma. Then, they review how their colleagues would proceed based on results of a social media poll of Glaucoma Today’s audience.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of “Survey Says” With I. Paul Singh, MD, a special edition of <em>GT: The Podcast</em>, Dr. Singh is joined by guests<em> </em>Oluwatosin Smith, MD, and Jason Bacharach, MD. The panel delves into the benefits and challenges of having a wide array of treatment options for glaucoma and how they approach decisions about surgical intervention. Later, they weigh in on the case in question, offering their thoughts on the target IOP and treatment goals for a patient with moderate primary open-angle glaucoma. Then, they review how their colleagues would proceed based on results of a social media poll of <em>Glaucoma Today’s</em> audience.</p>]]>
      </content:encoded>
      <itunes:duration>3489</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c97010e6-4292-11ee-a663-cbd265224d8a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4106293500.mp3?updated=1692909449" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Suprachoroidal Hemorrhage</title>
      <description>Jessica Randolph, MD, recaps her article, “Suprachoroidal Hemorrhage,” which was written with Melissa Suggs, MS, MS, and featured in the March/April issue of Glaucoma Today. This article reviews the fundamentals of managing suprachoroidal hemorrhage, a rare but serious complication of intraocular surgery that can cause significant vision loss. </description>
      <pubDate>Tue, 25 Jul 2023 16:00:31 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Jessica Randolph, MD, recaps her article, “Suprachoroidal Hemorrhage,” which was written with Melissa Suggs, MS, MS, and featured in the March/April issue of Glaucoma Today. This article reviews the fundamentals of managing suprachoroidal hemorrhage, a rare but serious complication of intraocular surgery that can cause significant vision loss. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Jessica Randolph, MD, recaps her article, “Suprachoroidal Hemorrhage,” which was written with Melissa Suggs, MS, MS, and featured in the March/April issue of <em>Glaucoma Today</em>. This article reviews the fundamentals of managing suprachoroidal hemorrhage, a rare but serious complication of intraocular surgery that can cause significant vision loss. </p>]]>
      </content:encoded>
      <itunes:duration>483</itunes:duration>
      <guid isPermaLink="false"><![CDATA[96fba1da-2b03-11ee-880a-5b6e53d7f41c]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4330135589.mp3?updated=1690300791" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Waste in Ophthalmology ORs</title>
      <description>Marko Oydanich, MD, discusses the growing environmental burden of the health care sector, as featured in an article he wrote with Albert Khouri, MD, and Jasmine Mahajan, BS, for a recent issue of Glaucoma Today. Dr. Oydanich offers strategies for reducing waste in ophthalmology ORs, much of which results from single-use equipment and devices. Later, David Chang, MD, shares the mission of EyeSustain.org, a web-based resource center for sustainability in ophthalmology, as covered in an article written with Cassandra Thiel, PhD, and featured in GT.</description>
      <pubDate>Mon, 26 Jun 2023 21:23:10 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Marko Oydanich, MD, discusses the growing environmental burden of the health care sector, as featured in an article he wrote with Albert Khouri, MD, and Jasmine Mahajan, BS, for a recent issue of Glaucoma Today. Dr. Oydanich offers strategies for reducing waste in ophthalmology ORs, much of which results from single-use equipment and devices. Later, David Chang, MD, shares the mission of EyeSustain.org, a web-based resource center for sustainability in ophthalmology, as covered in an article written with Cassandra Thiel, PhD, and featured in GT.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Marko Oydanich, MD, discusses the growing environmental burden of the health care sector, as featured in an article he wrote with Albert Khouri, MD, and Jasmine Mahajan, BS, for a recent issue of <em>Glaucoma Today</em>. Dr. Oydanich offers strategies for reducing waste in ophthalmology ORs, much of which results from single-use equipment and devices. Later, David Chang, MD, shares the mission of EyeSustain.org, a web-based resource center for sustainability in ophthalmology, as covered in an article written with Cassandra Thiel, PhD, and featured in <em>GT.</em></p>]]>
      </content:encoded>
      <itunes:duration>873</itunes:duration>
      <guid isPermaLink="false"><![CDATA[5d8a28e8-145d-11ee-887b-4f62d12d89d7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1835281775.mp3?updated=1687810473" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Patients on Reddit</title>
      <description>Richie Kahn, a rare ophthalmic disease patient and co-founder and principal of Canary Advisors, recaps his article—“Patients on Reddit”—from the March/April issue of Glaucoma Today. In this article, Kahn discusses the usefulness of the forum-style social media platform Reddit for allowing patients to connect, share stories, and ask questions. While the platform facilitates connection and support, the credibility of the information shared may be lacking. </description>
      <pubDate>Tue, 23 May 2023 19:57:05 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Richie Kahn, a rare ophthalmic disease patient and co-founder and principal of Canary Advisors, recaps his article—“Patients on Reddit”—from the March/April issue of Glaucoma Today. In this article, Kahn discusses the usefulness of the forum-style social media platform Reddit for allowing patients to connect, share stories, and ask questions. While the platform facilitates connection and support, the credibility of the information shared may be lacking. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Richie Kahn, a rare ophthalmic disease patient and co-founder and principal of Canary Advisors, recaps his article—“Patients on Reddit”—from the March/April issue of <em>Glaucoma Today</em>. In this article, Kahn discusses the usefulness of the forum-style social media platform Reddit for allowing patients to connect, share stories, and ask questions. While the platform facilitates connection and support, the credibility of the information shared may be lacking. </p>]]>
      </content:encoded>
      <itunes:duration>515</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c254165a-f9a3-11ed-968e-73241dc161d1]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1179178340.mp3?updated=1684872025" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Noninvasive Trabeculotomy Treatment for Glaucoma</title>
      <description>Ticiana De Francesco, MD, shares an update on the first-in-human experience with femtosecond laser image-guided high-precision trabeculotomy, or FLIGHT (ViaLase), as covered in an article she coauthored with Iqbal Ike K. Ahmed, MD, FRCSC, for an upcoming issue of Glaucoma Today. Dr. De Francesco describes the new procedure and how it could help expand options for safe and effective glaucoma intervention.</description>
      <pubDate>Wed, 26 Apr 2023 17:50:03 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Ticiana De Francesco, MD, shares an update on the first-in-human experience with femtosecond laser image-guided high-precision trabeculotomy, or FLIGHT (ViaLase), as covered in an article she coauthored with Iqbal Ike K. Ahmed, MD, FRCSC, for an upcoming issue of Glaucoma Today. Dr. De Francesco describes the new procedure and how it could help expand options for safe and effective glaucoma intervention.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Ticiana De Francesco, MD, shares an update on the first-in-human experience with femtosecond laser image-guided high-precision trabeculotomy, or FLIGHT (ViaLase), as covered in an article she coauthored with Iqbal Ike K. Ahmed, MD, FRCSC, for an upcoming issue of <em>Glaucoma Today</em>. Dr. De Francesco describes the new procedure and how it could help expand options for safe and effective glaucoma intervention.</p>]]>
      </content:encoded>
      <itunes:duration>476</itunes:duration>
      <guid isPermaLink="false"><![CDATA[5fb83930-e45a-11ed-8128-8b10ed6ba73d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3973102642.mp3?updated=1682531532" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Remote Monitoring of Glaucoma</title>
      <description>Susan Liang, MD, assistant professor at Tufts University School of Medicine in Boston and clinical director at New England Eye Center, Framingham, recaps her article—“Remote Monitoring of Glaucoma”—from the November/December issue of Glaucoma Today. In this article, Dr. Liang outlines existing and developing technologies designed to enable high-quality virtual care today and in the future.</description>
      <pubDate>Wed, 22 Mar 2023 18:29:19 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Susan Liang, MD, assistant professor at Tufts University School of Medicine in Boston and clinical director at New England Eye Center, Framingham, recaps her article—“Remote Monitoring of Glaucoma”—from the November/December issue of Glaucoma Today. In this article, Dr. Liang outlines existing and developing technologies designed to enable high-quality virtual care today and in the future.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Susan Liang, MD, assistant professor at Tufts University School of Medicine in Boston and clinical director at New England Eye Center, Framingham, recaps her article—“Remote Monitoring of Glaucoma”—from the November/December issue of <em>Glaucoma Today</em>. In this article, Dr. Liang outlines existing and developing technologies designed to enable high-quality virtual care today and in the future.</p>]]>
      </content:encoded>
      <itunes:duration>902</itunes:duration>
      <guid isPermaLink="false"><![CDATA[497f59a2-c8d8-11ed-be48-3fe3a0b2c9af]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2817519507.mp3?updated=1679506980" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Retinal Nerve Fiber Layer Optical Texture Analysis</title>
      <description>Christopher K.S. Leung, MD, MB ChB, chairperson and clinical professor for the Department of Ophthalmology at The University of Hong Kong School of Clinical Medicine, recaps his article—“Retinal Nerve Fiber Layer Optical Texture Analysis”—from the November/December issue of Glaucoma Today. In the article, Dr. Leung describes RNFL Optical Texture Analysis, an algorithm to uncover the optical texture and trajectories of individual axonal fiber bundles, which may help to identify RNFL defects in early and advanced glaucoma.</description>
      <pubDate>Wed, 22 Feb 2023 15:58:02 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Christopher K.S. Leung, MD, MB ChB, chairperson and clinical professor for the Department of Ophthalmology at The University of Hong Kong School of Clinical Medicine, recaps his article—“Retinal Nerve Fiber Layer Optical Texture Analysis”—from the November/December issue of Glaucoma Today. In the article, Dr. Leung describes RNFL Optical Texture Analysis, an algorithm to uncover the optical texture and trajectories of individual axonal fiber bundles, which may help to identify RNFL defects in early and advanced glaucoma.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Christopher K.S. Leung, MD, MB ChB, chairperson and clinical professor for the Department of Ophthalmology at The University of Hong Kong School of Clinical Medicine, recaps his article—“Retinal Nerve Fiber Layer Optical Texture Analysis”—from the November/December issue of <em>Glaucoma Today</em>. In the article, Dr. Leung describes RNFL Optical Texture Analysis, an algorithm to uncover the optical texture and trajectories of individual axonal fiber bundles, which may help to identify RNFL defects in early and advanced glaucoma.</p>]]>
      </content:encoded>
      <itunes:duration>598</itunes:duration>
      <guid isPermaLink="false"><![CDATA[64f61ed0-b2c8-11ed-a0b3-f35886a6173f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9978344790.mp3?updated=1677081227" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Teleophthalmology for Incidental Glaucoma Screening</title>
      <description>In this episode of GT: The Podcast, Roshun D. Sangani, MD, recaps his article, “Incidental Glaucoma Screening Using Teleophthalmology at a Tertiary Care Ophthalmology Center,” written with Albert Khouri, MD, and featured in the September/October issue of Glaucoma Today. A novel approach to the detection and management of glaucoma in a busy emergency department aims to minimize the number of visits before intervention, treat patients earlier, and encourage follow-up.</description>
      <pubDate>Thu, 19 Jan 2023 17:31:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode of GT: The Podcast, Roshun D. Sangani, MD, recaps his article, “Incidental Glaucoma Screening Using Teleophthalmology at a Tertiary Care Ophthalmology Center,” written with Albert Khouri, MD, and featured in the September/October issue of Glaucoma Today. A novel approach to the detection and management of glaucoma in a busy emergency department aims to minimize the number of visits before intervention, treat patients earlier, and encourage follow-up.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode of GT: The Podcast, Roshun D. Sangani, MD, recaps his article, “Incidental Glaucoma Screening Using Teleophthalmology at a Tertiary Care Ophthalmology Center,” written with Albert Khouri, MD, and featured in the September/October issue of <em>Glaucoma Today</em>. A novel approach to the detection and management of glaucoma in a busy emergency department aims to minimize the number of visits before intervention, treat patients earlier, and encourage follow-up.</p>]]>
      </content:encoded>
      <itunes:duration>485</itunes:duration>
      <guid isPermaLink="false"><![CDATA[01b04696-9849-11ed-8c29-1bfcccf5d429]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4035980394.mp3?updated=1674167785" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Procedure and IOL Selection</title>
      <description>On this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Shamil Patel, MD, MBA, and Manjool Shah, MD. The panel will discuss how they would approach procedure and IOL selection for a real patient case, and later, they find out how their colleagues chose to proceed based on the results of a social media poll of Glaucoma Today’s audience. </description>
      <pubDate>Wed, 14 Dec 2022 11:46:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>On this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Shamil Patel, MD, MBA, and Manjool Shah, MD. The panel will discuss how they would approach procedure and IOL selection for a real patient case, and later, they find out how their colleagues chose to proceed based on the results of a social media poll of Glaucoma Today’s audience. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>On this episode of “Survey Says” With I. Paul Singh, MD, a special edition of <em>GT: The Podcast</em>, Dr. Singh is joined by guests Shamil Patel, MD, MBA, and Manjool Shah, MD. The panel will discuss how they would approach procedure and IOL selection for a real patient case, and later, they find out how their colleagues chose to proceed based on the results of a social media poll of <em>Glaucoma Today’s</em> audience. </p>]]>
      </content:encoded>
      <itunes:duration>2648</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f192f272-7bce-11ed-a4e9-1f5fa550fad1]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3196800222.mp3?updated=1674137448" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Leading Through Uncertainty</title>
      <description>In this episode of GT: The Podcast, Zaiba Malik, MD, recaps her article, “Leading Through Uncertainty,” written with Michael Onuscheck, and featured in the September/October issue of Glaucoma Today. Change and disruption are inevitable in medicine, and good leadership requires the ability to embrace uncertainty. Dr. Malik discusses different types of uncertainty and the necessary tools to overcome challenges and maintain strong leadership.</description>
      <pubDate>Tue, 15 Nov 2022 18:39:18 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode of GT: The Podcast, Zaiba Malik, MD, recaps her article, “Leading Through Uncertainty,” written with Michael Onuscheck, and featured in the September/October issue of Glaucoma Today. Change and disruption are inevitable in medicine, and good leadership requires the ability to embrace uncertainty. Dr. Malik discusses different types of uncertainty and the necessary tools to overcome challenges and maintain strong leadership.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode of GT: The Podcast, Zaiba Malik, MD, recaps her article, “Leading Through Uncertainty,” written with Michael Onuscheck, and featured in the September/October issue of <em>Glaucoma Today</em>. Change and disruption are inevitable in medicine, and good leadership requires the ability to embrace uncertainty. Dr. Malik discusses different types of uncertainty and the necessary tools to overcome challenges and maintain strong leadership.</p>]]>
      </content:encoded>
      <itunes:duration>448</itunes:duration>
      <guid isPermaLink="false"><![CDATA[923d7fb6-6514-11ed-816b-dffd5a6393a6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8584191791.mp3?updated=1668537755" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Physician Burnout in Ophthalmology</title>
      <description>In this episode of GT: The Podcast, Leonard K. Seibold, MD, recaps his article, “Physician Burnout in Ophthalmology,” written with Jessica A. Sedhom, MD, and featured in the September/October issue of Glaucoma Today. The article discusses burnout syndrome and its increasing prevalence among physicians, as well as results of a survey to determine burnout rates among ophthalmologists and identify the major risk factors for burnout syndrome.</description>
      <pubDate>Fri, 14 Oct 2022 16:36:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode of GT: The Podcast, Leonard K. Seibold, MD, recaps his article, “Physician Burnout in Ophthalmology,” written with Jessica A. Sedhom, MD, and featured in the September/October issue of Glaucoma Today. The article discusses burnout syndrome and its increasing prevalence among physicians, as well as results of a survey to determine burnout rates among ophthalmologists and identify the major risk factors for burnout syndrome.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode of GT: The Podcast, Leonard K. Seibold, MD, recaps his article, “Physician Burnout in Ophthalmology,” written with Jessica A. Sedhom, MD, and featured in the September/October issue of <em>Glaucoma Today</em>. The article discusses burnout syndrome and its increasing prevalence among physicians, as well as results of a survey to determine burnout rates among ophthalmologists and identify the major risk factors for burnout syndrome.</p>]]>
      </content:encoded>
      <itunes:duration>554</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d89c1d7e-4bff-11ed-8f8e-2bbd2a49733d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9016283067.mp3?updated=1665780108" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Survey Says: Determining Target IOP and Next Steps</title>
      <description>In this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Analisa Arosemena MD, from Aran Eye Associates in Miami, Florida, and Lorraine Provencher, MD, from Cincinnati Eye Institute in Cincinnati, Ohio. The panel discuss how they would treat the patient in question and, later, they find out how their colleagues would approach treatment, based on the results of a social media poll of Glaucoma Today’s audience. In terms of target IOP and preferred treatment, how do the different opinions match up?</description>
      <pubDate>Tue, 13 Sep 2022 21:07:57 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Analisa Arosemena MD, from Aran Eye Associates in Miami, Florida, and Lorraine Provencher, MD, from Cincinnati Eye Institute in Cincinnati, Ohio. The panel discuss how they would treat the patient in question and, later, they find out how their colleagues would approach treatment, based on the results of a social media poll of Glaucoma Today’s audience. In terms of target IOP and preferred treatment, how do the different opinions match up?</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode of “Survey Says” With I. Paul Singh, MD, a special edition of <em>GT: The Podcast</em>, Dr. Singh is joined by guests Analisa Arosemena MD, from Aran Eye Associates in Miami, Florida, and Lorraine Provencher, MD, from Cincinnati Eye Institute in Cincinnati, Ohio. The panel discuss how they would treat the patient in question and, later, they find out how their colleagues would approach treatment, based on the results of a social media poll of <em>Glaucoma Today’s</em> audience. In terms of target IOP and preferred treatment, how do the different opinions match up?</p>]]>
      </content:encoded>
      <itunes:duration>2409</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1fe139d6-33a4-11ed-991d-eb25741eb4f2]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4478219409.mp3?updated=1663101855" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Glaucoma Visionaries: Sean Ianchulev, MD, MPH</title>
      <description>In this episode, hear an interview with Sean Ianchulev, MD, MPH, who was nominated by the Glaucoma Today editorial advisory board to be featured in a recent issue as an influential innovator. In this interview, Dr. Ianchulev describes his journey into medicine, how he discovered his interest in glaucoma, what keeps him motivated to innovate, and what advances he hopes to see for the subspecialty in the future.</description>
      <pubDate>Wed, 17 Aug 2022 17:15:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode, hear an interview with Sean Ianchulev, MD, MPH, who was nominated by the Glaucoma Today editorial advisory board to be featured in a recent issue as an influential innovator. In this interview, Dr. Ianchulev describes his journey into medicine, how he discovered his interest in glaucoma, what keeps him motivated to innovate, and what advances he hopes to see for the subspecialty in the future.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode, hear an interview with Sean Ianchulev, MD, MPH, who was nominated by the <em>Glaucoma Today</em> editorial advisory board to be featured in a recent issue as an influential innovator. In this interview, Dr. Ianchulev describes his journey into medicine, how he discovered his interest in glaucoma, what keeps him motivated to innovate, and what advances he hopes to see for the subspecialty in the future.</p>]]>
      </content:encoded>
      <itunes:duration>737</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b2ad896a-1e71-11ed-b2ee-23faf47486a6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2797058556.mp3?updated=1660771235" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Glaucoma Visionaries: Joel S. Schuman, MD, FACS</title>
      <description>In this episode, hear an interview with Joel S. Schuman, MD, FACS, who was nominated by the Glaucoma Today editorial advisory board to be featured in the publication as an influential innovator. In this interview, Dr. Schuman shares what sparked his initial interest in glaucoma, discusses his role in the development of OCT imaging, and describes why he thinks a cure for high IOP in glaucoma could be on the horizon.</description>
      <pubDate>Fri, 15 Jul 2022 16:29:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode, hear an interview with Joel S. Schuman, MD, FACS, who was nominated by the Glaucoma Today editorial advisory board to be featured in the publication as an influential innovator. In this interview, Dr. Schuman shares what sparked his initial interest in glaucoma, discusses his role in the development of OCT imaging, and describes why he thinks a cure for high IOP in glaucoma could be on the horizon.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode, hear an interview with Joel S. Schuman, MD, FACS, who was nominated by the <em>Glaucoma Today </em>editorial advisory board to be featured in the publication as an influential innovator. In this interview, Dr. Schuman shares what sparked his initial interest in glaucoma, discusses his role in the development of OCT imaging, and describes why he thinks a cure for high IOP in glaucoma could be on the horizon.</p>]]>
      </content:encoded>
      <itunes:duration>622</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c1b16310-0453-11ed-874d-472defcf8cdc]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3812531420.mp3?updated=1657899630" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>‘Survey Says’ With I. Paul Singh, MD</title>
      <description>In this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Deborah Ristvedt, DO, of Vance Thompson Vision, and Shamik Bafna, MD, of Cleveland Eye Clinic. The guests are presented with a real patient case and asked to weigh in on how they would manage it. Later, Dr. Singh shares the Glaucoma Today audience’s preferred approach to the case, based on the results of a social media poll. How do the polling results match up against the thoughts of today’s panelists? </description>
      <pubDate>Wed, 15 Jun 2022 16:30:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Deborah Ristvedt, DO, of Vance Thompson Vision, and Shamik Bafna, MD, of Cleveland Eye Clinic. The guests are presented with a real patient case and asked to weigh in on how they would manage it. Later, Dr. Singh shares the Glaucoma Today audience’s preferred approach to the case, based on the results of a social media poll. How do the polling results match up against the thoughts of today’s panelists? </itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode of “Survey Says” With I. Paul Singh, MD, a special edition of <em>GT: The Podcast,</em> Dr. Singh is joined by guests Deborah Ristvedt, DO, of Vance Thompson Vision, and Shamik Bafna, MD, of Cleveland Eye Clinic. The guests are presented with a real patient case and asked to weigh in on how they would manage it. Later, Dr. Singh shares the <em>Glaucoma Today</em> audience’s preferred approach to the case, based on the results of a social media poll. How do the polling results match up against the thoughts of today’s panelists? </p>]]>
      </content:encoded>
      <itunes:duration>2478</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fb8a4416-ece9-11ec-bb27-a76c9dcc958e]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5198247249.mp3?updated=1674137587" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Glaucoma Visionaries: Malik Y. Kahook, MD</title>
      <description>In this episode, hear an interview with Malik Y. Kahook, MD, who was nominated by the Glaucoma Today editorial advisory board to be featured in the January/February issue as an influential innovator. His desire to improve medical and surgical approaches in ophthalmology has led him to invent and develop numerous technologies over the years. Dr. Kahook discusses some of these innovations, shares why he’s constantly looking for better solutions, and offers his advice to ophthalmologists who want to follow a similar path.</description>
      <pubDate>Tue, 24 May 2022 15:50:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode, hear an interview with Malik Y. Kahook, MD, who was nominated by the Glaucoma Today editorial advisory board to be featured in the January/February issue as an influential innovator. His desire to improve medical and surgical approaches in ophthalmology has led him to invent and develop numerous technologies over the years. Dr. Kahook discusses some of these innovations, shares why he’s constantly looking for better solutions, and offers his advice to ophthalmologists who want to follow a similar path.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode, hear an interview with Malik Y. Kahook, MD, who was nominated by the <em>Glaucoma Today</em> editorial advisory board to be featured in the January/February issue as an influential innovator. His desire to improve medical and surgical approaches in ophthalmology has led him to invent and develop numerous technologies over the years. Dr. Kahook discusses some of these innovations, shares why he’s constantly looking for better solutions, and offers his advice to ophthalmologists who want to follow a similar path.</p>]]>
      </content:encoded>
      <itunes:duration>521</itunes:duration>
      <guid isPermaLink="false"><![CDATA[cde47c58-db9a-11ec-a620-bbd86351d8d6]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7702890773.mp3?updated=1653422147" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Remote Diagnostics for Closer Clinical Teamwork</title>
      <description>Richie Kahn, MPH, a clinical researcher and patient advocate, leads a discussion between physicians and patients on the use and value of home monitoring technology in ophthalmology. Kahn, who is also a patient with a rare and progressive form of optic atrophy as well as a clinical trial participant, is joined by Barbara Wirostko, MD, FARVO; Craig Chaya, MD; and Dorian De Maio, a long-time glaucoma patient of Drs. Wirostko and Chaya.</description>
      <pubDate>Wed, 20 Apr 2022 17:39:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Richie Kahn, MPH, a clinical researcher and patient advocate, leads a discussion between physicians and patients on the use and value of home monitoring technology in ophthalmology. Kahn, who is also a patient with a rare and progressive form of optic atrophy as well as a clinical trial participant, is joined by Barbara Wirostko, MD, FARVO; Craig Chaya, MD; and Dorian De Maio, a long-time glaucoma patient of Drs. Wirostko and Chaya.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Richie Kahn, MPH, a clinical researcher and patient advocate, leads a discussion between physicians and patients on the use and value of home monitoring technology in ophthalmology. Kahn, who is also a patient with a rare and progressive form of optic atrophy as well as a clinical trial participant, is joined by Barbara Wirostko, MD, FARVO; Craig Chaya, MD; and Dorian De Maio, a long-time glaucoma patient of Drs. Wirostko and Chaya.</p>]]>
      </content:encoded>
      <itunes:duration>2290</itunes:duration>
      <guid isPermaLink="false"><![CDATA[573e1d56-c0f2-11ec-a47a-8b213e29904d]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5000885063.mp3?updated=1674137860" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Introducing 'Survey Says' With I. Paul Singh, MD</title>
      <description>In this special edition of GT: The Podcast, I. Paul Singh, MD, presents real patients’ cases from his practice and asks guests Joseph F. Panarelli, MD, and Sahar Bedrood, MD, PhD, to explain how they each would manage these patients. Dr. Singh then shares the results of social media poll questions in which the Glaucoma Today audience voted on its preferred approaches to these cases. Did the polling results match up with the proposed approaches of Drs. Panarelli and Bedrood? </description>
      <pubDate>Thu, 17 Mar 2022 20:55:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this special edition of GT: The Podcast, I. Paul Singh, MD, presents real patients’ cases from his practice and asks guests Joseph F. Panarelli, MD, and Sahar Bedrood, MD, PhD, to explain how they each would manage these patients. Dr. Singh then shares the results of social media poll questions in which the Glaucoma Today audience voted on its preferred approaches to these cases. Did the polling results match up with the proposed approaches of Drs. Panarelli and Bedrood? </itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special edition of GT: The Podcast, I. Paul Singh, MD, presents real patients’ cases from his practice and asks guests Joseph F. Panarelli, MD, and Sahar Bedrood, MD, PhD, to explain how they each would manage these patients. Dr. Singh then shares the results of social media poll questions in which the <em>Glaucoma Today</em> audience voted on its preferred approaches to these cases. Did the polling results match up with the proposed approaches of Drs. Panarelli and Bedrood? </p>]]>
      </content:encoded>
      <itunes:duration>2321</itunes:duration>
      <guid isPermaLink="false"><![CDATA[8c5e0268-a634-11ec-a18f-3b2f91ff7601]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9452212923.mp3?updated=1674137945" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Lessons In Dissatisfaction • Not Your Grandma’s Puff Test</title>
      <description>This double episode of GT: The Podcast features a pair of articles published in the November/December 2021 issue of Glaucoma Today. In part one, Finny T. John, MD, and Natasha Nayak Kolomeyer, MD, recap their article, “Lessons in Dissatisfaction,” which shares surgical insight gained from challenging encounters in the clinic and OR. Then, Alexandra Papp, MD, CAPT, USAF, MC, reads her article, “Not Your Grandma’s Puff Test,” which reviews the importance of measuring corneal hysteresis (CH) to determine the risk of glaucomatous progression. </description>
      <pubDate>Wed, 16 Feb 2022 11:17:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>This double episode of GT: The Podcast features a pair of articles published in the November/December 2021 issue of Glaucoma Today. In part one, Finny T. John, MD, and Natasha Nayak Kolomeyer, MD, recap their article, “Lessons in Dissatisfaction,” which shares surgical insight gained from challenging encounters in the clinic and OR. Then, Alexandra Papp, MD, CAPT, USAF, MC, reads her article, “Not Your Grandma’s Puff Test,” which reviews the importance of measuring corneal hysteresis (CH) to determine the risk of glaucomatous progression. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>This double episode of GT: The Podcast features a pair of articles published in the November/December 2021 issue of <em>Glaucoma Today</em>. In part one, Finny T. John, MD, and Natasha Nayak Kolomeyer, MD,<strong> </strong>recap their article, “Lessons in Dissatisfaction,” which shares surgical insight gained from challenging encounters in the clinic and OR.<strong> </strong>Then, Alexandra Papp, MD, CAPT, USAF, MC, reads her article, “Not Your Grandma’s Puff Test,” which reviews the importance of measuring corneal hysteresis (CH) to determine the risk of glaucomatous progression. </p>]]>
      </content:encoded>
      <itunes:duration>707</itunes:duration>
      <guid isPermaLink="false"><![CDATA[ea4cfc6a-8f43-11ec-a120-33f8cb41a85a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7445415723.mp3?updated=1645028539" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>A Holistic Approach to Glaucoma Care</title>
      <description>Alexandra “Ola” Pietraszkiewicz, MD, reads her article, "A Holistic Approach to Glaucoma Care," from the September/October issue of Glaucoma Today. This article highlights the correlation between vision loss and mental health and discusses how a greater understanding of the psychosocial determinants of health can improve patient-physician relationships and clinical outcomes.</description>
      <pubDate>Thu, 20 Jan 2022 12:12:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Alexandra “Ola” Pietraszkiewicz, MD, reads her article, "A Holistic Approach to Glaucoma Care," from the September/October issue of Glaucoma Today. This article highlights the correlation between vision loss and mental health and discusses how a greater understanding of the psychosocial determinants of health can improve patient-physician relationships and clinical outcomes.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Alexandra “Ola” Pietraszkiewicz, MD, reads her article, "A Holistic Approach to Glaucoma Care," from the September/October issue of <em>Glaucoma Today</em>. This article highlights the correlation between vision loss and mental health and discusses how a greater understanding of the psychosocial determinants of health can improve patient-physician relationships and clinical outcomes.</p>]]>
      </content:encoded>
      <itunes:duration>460</itunes:duration>
      <guid isPermaLink="false"><![CDATA[2bda42b8-7a14-11ec-be18-4fb44f3209c0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9705178705.mp3?updated=1642699059" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Reducing Pigment Particles in the Anterior Chamber</title>
      <description>Daniel Laroche, MD, reads his article, "Reducing Pigment Particles in the Anterior Chamber," written with Jose Sinon for the September/October issue of Glaucoma Today. This article reviews the several interventions which can be used to reduce the number of pigment particles in adult patients with pigment dispersion syndromes.</description>
      <pubDate>Mon, 20 Dec 2021 17:48:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Daniel Laroche, MD, reads his article, "Reducing Pigment Particles in the Anterior Chamber," written with Jose Sinon for the September/October issue of Glaucoma Today. This article reviews the several interventions which can be used to reduce the number of pigment particles in adult patients with pigment dispersion syndromes.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Daniel Laroche, MD, reads his article, "Reducing Pigment Particles in the Anterior Chamber," written with Jose Sinon for the September/October issue of <em>Glaucoma Today. </em>This article reviews the several interventions which can be used to reduce the number of pigment particles in adult patients with pigment dispersion syndromes.</p>]]>
      </content:encoded>
      <itunes:duration>564</itunes:duration>
      <guid isPermaLink="false"><![CDATA[118a2814-61e7-11ec-b67b-eb71926f8d23]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2317239995.mp3?updated=1640040860" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dose &amp; Delivery: Defining Target IOP Ranges</title>
      <description>Nathan M. Radcliffe, MD, and Davinder S. Grover, MD, MPH, join Inder Paul Singh, MD, for an in-depth discussion on IOP. The trio discuss their criteria for defining IOP ranges, how they use hysteresis to predict pressure fluctuations, and the complications which may arise when a patient’s pressure creeps outside the defined ranges. </description>
      <pubDate>Fri, 10 Dec 2021 20:49:33 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Nathan M. Radcliffe, MD, and Davinder S. Grover, MD, MPH, join Inder Paul Singh, MD, for an in-depth discussion on IOP. The trio discuss their criteria for defining IOP ranges, how they use hysteresis to predict pressure fluctuations, and the complications which may arise when a patient’s pressure creeps outside the defined ranges. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Nathan M. Radcliffe, MD, and Davinder S. Grover, MD, MPH, join Inder Paul Singh, MD, for an in-depth discussion on IOP. The trio discuss their criteria for defining IOP ranges, how they use hysteresis to predict pressure fluctuations, and the complications which may arise when a patient’s pressure creeps outside the defined ranges. </p>]]>
      </content:encoded>
      <itunes:duration>2332</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d588f962-59f8-11ec-8fb7-13bcc5101b5f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1554253668.mp3?updated=1639168891" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Is It Time to Rethink the Slit Lamp?</title>
      <description>Nikola Ragusa, MD, reads his article, "Is It Time to Rethink the Slit Lamp?" from the July/August issue of Glaucoma Today. This article reviews a practice-based survey that considers patient comfort during eye exams and challenges for the redevelopment of certain ophthalmic equipment to promote greater accessibility.</description>
      <pubDate>Thu, 18 Nov 2021 15:50:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Nikola Ragusa, MD, reads his article, "Is It Time to Rethink the Slit Lamp?" from the July/August issue of Glaucoma Today. This article reviews a practice-based survey that considers patient comfort during eye exams and challenges for the redevelopment of certain ophthalmic equipment to promote greater accessibility.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Nikola Ragusa, MD, reads his article, "Is It Time to Rethink the Slit Lamp?" from the July/August issue of <em>Glaucoma Today</em>. This article reviews a practice-based survey that considers patient comfort during eye exams and challenges for the redevelopment of certain ophthalmic equipment to promote greater accessibility.</p>]]>
      </content:encoded>
      <itunes:duration>561</itunes:duration>
      <guid isPermaLink="false"><![CDATA[397f8eda-48b1-11ec-8a08-df8558163db7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8852917904.mp3?updated=1637268955" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>The Contrast Sensitivity Story</title>
      <description>Brian M. Shafer, MD, reads his article, “The Contrast Sensitivity Story,” from the July/August 2021 issue of Glaucoma Today. In this article, Dr. Shafer looks at contrast sensitivity in patients with glaucoma and challenges what he says is the old dogma that physicians shouldn't implant multifocal IOLs in these patients.</description>
      <pubDate>Thu, 21 Oct 2021 20:08:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Brian M. Shafer, MD, reads his article, “The Contrast Sensitivity Story,” from the July/August 2021 issue of Glaucoma Today. In this article, Dr. Shafer looks at contrast sensitivity in patients with glaucoma and challenges what he says is the old dogma that physicians shouldn't implant multifocal IOLs in these patients.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Brian M. Shafer, MD, reads his article, “The Contrast Sensitivity Story,” from the July/August 2021 issue of <em>Glaucoma Today</em>. In this article, Dr. Shafer looks at contrast sensitivity in patients with glaucoma and challenges what he says is the old dogma that physicians shouldn't implant multifocal IOLs in these patients.</p>]]>
      </content:encoded>
      <itunes:duration>481</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b9c4bf4c-32aa-11ec-b428-7fc44002fe23]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5571279510.mp3?updated=1634915746" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dose &amp; Delivery: New Mechanisms of Action</title>
      <description>Lorraine M. Provencher, MD, and Constance O. Okeke, MD, MSCE, join Inder Paul Singh, MD, to discuss new molecules and mechanisms of action. How do these new medications change the way physicians treat glaucoma?</description>
      <pubDate>Wed, 22 Sep 2021 18:55:36 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Lorraine M. Provencher, MD, and Constance O. Okeke, MD, MSCE, join Inder Paul Singh, MD, to discuss new molecules and mechanisms of action. How do these new medications change the way physicians treat glaucoma?</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Lorraine M. Provencher, MD, and Constance O. Okeke, MD, MSCE, join Inder Paul Singh, MD, to discuss new molecules and mechanisms of action. How do these new medications change the way physicians treat glaucoma?</p>]]>
      </content:encoded>
      <itunes:duration>1838</itunes:duration>
      <guid isPermaLink="false"><![CDATA[d831bf44-1bd4-11ec-a0ff-a74217b7a090]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3083746314.mp3?updated=1632336452" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>The New Attending’s Perspective on MIGS</title>
      <description>Erin Sieck, MD, Assistant Professor at the Washington University School of Medicine in St. Louis, and Georges M. Durr, MD, FRCSC, Assistant Professor at the Université de Montréal, Montreal, share their teaching pearls for mastering angle-based and subconjunctival MIGS procedures, as featured in their article in the May/June 2021 issue of Glaucoma Today.</description>
      <pubDate>Wed, 22 Sep 2021 18:55:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Erin Sieck, MD, Assistant Professor at the Washington University School of Medicine in St. Louis, and Georges M. Durr, MD, FRCSC, Assistant Professor at the Université de Montréal, Montreal, share their teaching pearls for mastering angle-based and subconjunctival MIGS procedures, as featured in their article in the May/June 2021 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Erin Sieck, MD, Assistant Professor at the Washington University School of Medicine in St. Louis, and Georges M. Durr, MD, FRCSC, Assistant Professor at the Université de Montréal, Montreal, share their teaching pearls for mastering angle-based and subconjunctival MIGS procedures, as featured in their article in the May/June 2021 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>844</itunes:duration>
      <guid isPermaLink="false"><![CDATA[069592c0-1bd5-11ec-9060-6b6b29c3d1a4]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL5643780611.mp3?updated=1632340889" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Complications With Xen Implantation and how to Avoid Them</title>
      <description>In the final episode of a three-part miniseries on navigating challenges after XEN Gel Stent (Allergan) implantation, Vanessa Vera, MD, and Luís Abegäo Pinto, MD, PhD—co-authors on a publication titled “Navigating Challenges After Xen”—explore atypical bleb morphologies after Xen implantation (prominent, nasal or avascular), how to treat and how to avoid these complications altogether.</description>
      <pubDate>Tue, 31 Aug 2021 11:48:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In the final episode of a three-part miniseries on navigating challenges after XEN Gel Stent (Allergan) implantation, Vanessa Vera, MD, and Luís Abegäo Pinto, MD, PhD—co-authors on a publication titled “Navigating Challenges After Xen”—explore atypical bleb morphologies after Xen implantation (prominent, nasal or avascular), how to treat and how to avoid these complications altogether.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In the final episode of a three-part miniseries on navigating challenges after XEN Gel Stent (Allergan) implantation, Vanessa Vera, MD, and Luís Abegäo Pinto, MD, PhD—co-authors on a publication titled “Navigating Challenges After Xen”—explore atypical bleb morphologies after Xen implantation (prominent, nasal or avascular), how to treat and how to avoid these complications altogether.</p>]]>
      </content:encoded>
      <itunes:duration>1603</itunes:duration>
      <guid isPermaLink="false"><![CDATA[eb49fbbe-0a72-11ec-bb99-7bd4e57d4df9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2082104244.mp3?updated=1674138336" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Tips and Tricks for the XEN Gel Stent</title>
      <description>In the second episode of this three-part miniseries, Oluwatosin Smith, MD, and Daniel Krivoy, MD, offer some surgical tips and tricks from their experience using the XEN Gel Stent (Allergan). Together, Drs. Smith and Krivoy offer techniques to manage complications such as clinical hypotony, migration, or dislocation.</description>
      <pubDate>Tue, 31 Aug 2021 11:47:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In the second episode of this three-part miniseries, Oluwatosin Smith, MD, and Daniel Krivoy, MD, offer some surgical tips and tricks from their experience using the XEN Gel Stent (Allergan). Together, Drs. Smith and Krivoy offer techniques to manage complications such as clinical hypotony, migration, or dislocation.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In the second episode of this three-part miniseries, Oluwatosin Smith, MD, and Daniel Krivoy, MD, offer some surgical tips and tricks from their experience using the XEN Gel Stent (Allergan). Together, Drs. Smith and Krivoy offer techniques to manage complications such as clinical hypotony, migration, or dislocation.</p>]]>
      </content:encoded>
      <itunes:duration>1427</itunes:duration>
      <guid isPermaLink="false"><![CDATA[cde17cdc-0a72-11ec-a65d-df3be8570703]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4688844557.mp3?updated=1630425174" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Navigating Post-Op Complications After Xen Microstent Implantation</title>
      <description>Manjool Shah, MD, and Steven R. Sarkisian Jr., MD, walk through the complications they faced after the implantation of the XEN Gel Stent (Allergan). Drs. Shah and Sarkisian discuss in detail the different risks presented in ab interno and ab externo cases—such as leaks, erosions, occlusions or obstructions—approaches to avoid these risks, and how to develop your surgical skills following complications. </description>
      <pubDate>Tue, 31 Aug 2021 11:45:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Manjool Shah, MD, and Steven R. Sarkisian Jr., MD, walk through the complications they faced after the implantation of the XEN Gel Stent (Allergan). Drs. Shah and Sarkisian discuss in detail the different risks presented in ab interno and ab externo cases—such as leaks, erosions, occlusions or obstructions—approaches to avoid these risks, and how to develop your surgical skills following complications. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Manjool Shah, MD, and Steven R. Sarkisian Jr., MD, walk through the complications they faced after the implantation of the XEN Gel Stent (Allergan). Drs. Shah and Sarkisian discuss in detail the different risks presented in ab interno and ab externo cases—such as leaks, erosions, occlusions or obstructions—approaches to avoid these risks, and how to develop your surgical skills following complications. </p>]]>
      </content:encoded>
      <itunes:duration>1861</itunes:duration>
      <guid isPermaLink="false"><![CDATA[af42be44-0a72-11ec-8ab1-bf228e51f652]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2646845020.mp3?updated=1674138507" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>A Superonasal Corneal Traction Suture for Ab Interno Xen Implantation</title>
      <description>David Woods, MD, reads his article, “A Superonasal Corneal Traction Suture for Ab Interno Xen Implantation,” from the May/June 2021 issue of Glaucoma Today. Here, he outlines his technique for ab interno implantation of the Xen Gel Stent (Allergan) using a superonasal corneal traction suture.</description>
      <pubDate>Thu, 19 Aug 2021 13:20:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>David Woods, MD, reads his article, “A Superonasal Corneal Traction Suture for Ab Interno Xen Implantation,” from the May/June 2021 issue of Glaucoma Today. Here, he outlines his technique for ab interno implantation of the Xen Gel Stent (Allergan) using a superonasal corneal traction suture.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>David Woods, MD, reads his article, “A Superonasal Corneal Traction Suture for Ab Interno Xen Implantation,” from the May/June 2021 issue of <em>Glaucoma Today</em>. Here, he outlines his technique for ab interno implantation of the Xen Gel Stent (Allergan) using a superonasal corneal traction suture.</p>]]>
      </content:encoded>
      <itunes:duration>482</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f05ea54c-0111-11ec-9b27-3f8a0ab8f9d9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2570063891.mp3?updated=1629394010" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>iStent inject W – Your go-to Device for MIGS Surgery</title>
      <description>In this special-edition of GT: The Podcast, Dr. Blake Williamson leads an expert surgical panel with Dr. Debbie Ristvedt and Dr. Mark Gallardo to discuss the benefits of the iStent inject W device. The panel reviews key features and clinical data, with a focus on how this impacts their treatment algorithm and they reveal why iStent inject W is their go-to MIGS device when treating patients with mild-to-moderate glaucoma undergoing cataract surgery.</description>
      <pubDate>Fri, 30 Jul 2021 11:37:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this special-edition of GT: The Podcast, Dr. Blake Williamson leads an expert surgical panel with Dr. Debbie Ristvedt and Dr. Mark Gallardo to discuss the benefits of the iStent inject W device. The panel reviews key features and clinical data, with a focus on how this impacts their treatment algorithm and they reveal why iStent inject W is their go-to MIGS device when treating patients with mild-to-moderate glaucoma undergoing cataract surgery.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special-edition of GT: The Podcast, Dr. Blake Williamson leads an expert surgical panel with Dr. Debbie Ristvedt and Dr. Mark Gallardo to discuss the benefits of the iStent <em>inject</em> W device. The panel reviews key features and clinical data, with a focus on how this impacts their treatment algorithm and they reveal why iStent <em>inject</em> W is their go-to MIGS device when treating patients with mild-to-moderate glaucoma undergoing cataract surgery.</p>]]>
      </content:encoded>
      <itunes:duration>916</itunes:duration>
      <guid isPermaLink="false"><![CDATA[508073fe-f14c-11eb-991d-ef94e3fbf2a7]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7695252294.mp3?updated=1627659863" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Pre-, Intra-, and Post-Operative Pearls for the MicroShunt</title>
      <description>In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2

1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.
2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.</description>
      <pubDate>Wed, 28 Jul 2021 17:23:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2

1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.
2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2</p><p><br></p><p>1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.</p><p>2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.</p>]]>
      </content:encoded>
      <itunes:duration>1662</itunes:duration>
      <guid isPermaLink="false"><![CDATA[235d0206-efea-11eb-80c5-ef7f7f1dbcdb]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3100467519.mp3?updated=1674138644" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Surgical Pearls From MicroShunt Implants</title>
      <description>In this special edition of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Michelle Lim, MD; Davinder Grover, MD; and James Brandt, MD, analyze their experience with the MicroShunt-a controlled micro-incisional ab-externo glaucoma filtration surgery device. Together, they share their surgical procedures and pearls, how to deal with the complications of post-op blebs, and proper mitomycin dosage based on the recent INN005 clinical trial findings.1  

1. Baker ND, Barnebey HS, Moster MR, et al; INN005 study group. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: 1-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021 :S0161-6420(21 )00384-00385.</description>
      <pubDate>Wed, 28 Jul 2021 17:21:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this special edition of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Michelle Lim, MD; Davinder Grover, MD; and James Brandt, MD, analyze their experience with the MicroShunt-a controlled micro-incisional ab-externo glaucoma filtration surgery device. Together, they share their surgical procedures and pearls, how to deal with the complications of post-op blebs, and proper mitomycin dosage based on the recent INN005 clinical trial findings.1  

1. Baker ND, Barnebey HS, Moster MR, et al; INN005 study group. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: 1-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021 :S0161-6420(21 )00384-00385.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special edition of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Michelle Lim, MD; Davinder Grover, MD; and James Brandt, MD, analyze their experience with the MicroShunt-a controlled micro-incisional ab-externo glaucoma filtration surgery device. Together, they share their surgical procedures and pearls, how to deal with the complications of post-op blebs, and proper mitomycin dosage based on the recent INN005 clinical trial findings.1  </p><p><br></p><p>1. Baker ND, Barnebey HS, Moster MR, et al; INN005 study group. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: 1-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021 :S0161-6420(21 )00384-00385.</p>]]>
      </content:encoded>
      <itunes:duration>2057</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fcd96d5e-efe9-11eb-9b3e-4725de85d726]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7519934389.mp3?updated=1674138701" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Equal Pay for Equal Work: Closing Ophthalmology’s Gender Gap in Compensation</title>
      <description>In this episode of GT: The Podcast, Lama Al-Aswad, MD, MPH, reads her article, “Equal Pay for Equal Work: Closing Ophthalmology’s Gender Gap in Compensation,” written with Sunidhi Ramesh, BS, and Aakriti Garg Shukla, MD, for the March/April 2021 issue of Glaucoma Today. This article takes a deep dive into the gender gap that still exists in the field of ophthalmology, breaks down the wage statistics, and looks at the multifactorial ways that the disparities in pay can be mitigated.</description>
      <pubDate>Tue, 20 Jul 2021 17:15:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode of GT: The Podcast, Lama Al-Aswad, MD, MPH, reads her article, “Equal Pay for Equal Work: Closing Ophthalmology’s Gender Gap in Compensation,” written with Sunidhi Ramesh, BS, and Aakriti Garg Shukla, MD, for the March/April 2021 issue of Glaucoma Today. This article takes a deep dive into the gender gap that still exists in the field of ophthalmology, breaks down the wage statistics, and looks at the multifactorial ways that the disparities in pay can be mitigated.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>GT: The Podcast, </em>Lama Al-Aswad, MD, MPH, reads her article, “Equal Pay for Equal Work: Closing Ophthalmology’s Gender Gap in Compensation,” written with Sunidhi Ramesh, BS, and Aakriti Garg Shukla, MD, for the March/April 2021 issue of <em>Glaucoma Today</em>. This article takes a deep dive into the gender gap that still exists in the field of ophthalmology, breaks down the wage statistics, and looks at the multifactorial ways that the disparities in pay can be mitigated.</p>]]>
      </content:encoded>
      <itunes:duration>710</itunes:duration>
      <guid isPermaLink="false"><![CDATA[fc1c5286-e97d-11eb-99fe-3b6ce8ad51a0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4562376092.mp3?updated=1626801588" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dose &amp; Delivery: Defining Controlled Glaucoma</title>
      <description>Deborah Ristvedt, DO, and Mark Gallardo, MD, join Inder Paul Singh, MD, to discuss what constitutes controlled glaucoma. How have their perspectives and management strategies evolved?</description>
      <pubDate>Tue, 22 Jun 2021 19:56:19 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Deborah Ristvedt, DO, and Mark Gallardo, MD, join Inder Paul Singh, MD, to discuss what constitutes controlled glaucoma. How have their perspectives and management strategies evolved?</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Deborah Ristvedt, DO, and Mark Gallardo, MD, join Inder Paul Singh, MD, to discuss what constitutes controlled glaucoma. How have their perspectives and management strategies evolved?</p>]]>
      </content:encoded>
      <itunes:duration>1843</itunes:duration>
      <guid isPermaLink="false"><![CDATA[f58268c2-d369-11eb-bbcb-637360b85f4a]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2302931073.mp3?updated=1624374061" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>In Advocation of Advocacy</title>
      <description>In this episode of GT: The Podcast, Lynn W. Sun, MD, PhD, reads her article, "In Advocation of Advocacy," from the March/April 2021 issue of Glaucoma Today. Dr. Sun makes her case for the importance of medical advocacy and describes how her fellow physicians can get involved.</description>
      <pubDate>Fri, 18 Jun 2021 19:39:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode of GT: The Podcast, Lynn W. Sun, MD, PhD, reads her article, "In Advocation of Advocacy," from the March/April 2021 issue of Glaucoma Today. Dr. Sun makes her case for the importance of medical advocacy and describes how her fellow physicians can get involved.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode of <em>GT: The Podcast, </em>Lynn W. Sun, MD, PhD, reads her article, "In Advocation of Advocacy," from the March/April 2021 issue of <em>Glaucoma Today</em>. Dr. Sun makes her case for the importance of medical advocacy and describes how her fellow physicians can get involved.</p>]]>
      </content:encoded>
      <itunes:duration>593</itunes:duration>
      <guid isPermaLink="false"><![CDATA[1ba9cd2e-d06d-11eb-92e2-a73576e87615]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7818859664.mp3?updated=1624386520" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Allyship: The Time is Now</title>
      <description>Lynn K. Gordon, MD, PhD, Emeritus Professor of Ophthalmology and Senior Associate Dean of the David Geffen School of Medicine at UCLA, Los Angeles, discusses the concept of allyship. She offers insight into what it means to be an ally and how effective allyship can help us achieve greater equity and inclusion, as featured in her article in the March/April 2021 issue of Glaucoma Today.</description>
      <pubDate>Thu, 27 May 2021 21:30:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Lynn K. Gordon, MD, PhD, Emeritus Professor of Ophthalmology and Senior Associate Dean of the David Geffen School of Medicine at UCLA, Los Angeles, discusses the concept of allyship. She offers insight into what it means to be an ally and how effective allyship can help us achieve greater equity and inclusion, as featured in her article in the March/April 2021 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Lynn K. Gordon, MD, PhD, Emeritus Professor of Ophthalmology and Senior Associate Dean of the David Geffen School of Medicine at UCLA, Los Angeles, discusses the concept of allyship. She offers insight into what it means to be an ally and how effective allyship can help us achieve greater equity and inclusion, as featured in her article in the March/April 2021 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>601</itunes:duration>
      <guid isPermaLink="false"><![CDATA[b2458d3c-bf32-11eb-995a-a7afa85e6e2b]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8311760489.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Novel Glaucoma Medications: From Clinical Trials to Clinical Experience</title>
      <description>Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of Glaucoma Today.</description>
      <pubDate>Tue, 27 Apr 2021 11:40:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>554</itunes:duration>
      <guid isPermaLink="false"><![CDATA[089b1660-a76f-11eb-b83e-c729f872fd11]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9491908084.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Dose &amp; Delivery: Evolutions in Glaucoma Management</title>
      <description>Welcome to episode 1 of Dose &amp; Delivery, a new podcast series from GT: the Podcast. Nathan Radcliffe, MD, and Steven R. Sarkisian Jr, MD, join Inder Paul Singh, MD, to discuss evolutions in their approaches to glaucoma management. Learn about their experiences with a bimatoprost intracameral implant (Durysta, Allergan).</description>
      <pubDate>Fri, 16 Apr 2021 19:36:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Welcome to episode 1 of Dose &amp; Delivery, a new podcast series from GT: the Podcast. Nathan Radcliffe, MD, and Steven R. Sarkisian Jr, MD, join Inder Paul Singh, MD, to discuss evolutions in their approaches to glaucoma management. Learn about their experiences with a bimatoprost intracameral implant (Durysta, Allergan).</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Welcome to episode 1 of Dose &amp; Delivery, a new podcast series from GT: the Podcast. Nathan Radcliffe, MD, and Steven R. Sarkisian Jr, MD, join Inder Paul Singh, MD, to discuss evolutions in their approaches to glaucoma management. Learn about their experiences with a bimatoprost intracameral implant (Durysta, Allergan).</p>]]>
      </content:encoded>
      <itunes:duration>2593</itunes:duration>
      <guid isPermaLink="false"><![CDATA[293f6196-9eeb-11eb-9751-bf9f41c3bb4f]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2140574937.mp3?updated=1674138939" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Visiting the Glaucoma Clinic in the Time of COVID-19</title>
      <description>Richie Kahn, MPH, a health policy professional, clinical researcher, and patient advisor, offers his perspective as a patient who has had to navigate visits to the glaucoma clinic over the past year. Also, Andrew Iwach, MD, discusses a video resource for patients that demonstrates the measures providers are taking to safely deliver glaucoma care during the pandemic, as featured in the January/February 2021 issue of Glaucoma Today.</description>
      <pubDate>Mon, 29 Mar 2021 15:07:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Richie Kahn, MPH, a health policy professional, clinical researcher, and patient advisor, offers his perspective as a patient who has had to navigate visits to the glaucoma clinic over the past year. Also, Andrew Iwach, MD, discusses a video resource for patients that demonstrates the measures providers are taking to safely deliver glaucoma care during the pandemic, as featured in the January/February 2021 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Richie Kahn, MPH, a health policy professional, clinical researcher, and patient advisor, offers his perspective as a patient who has had to navigate visits to the glaucoma clinic over the past year. Also, Andrew Iwach, MD, discusses a video resource for patients that demonstrates the measures providers are taking to safely deliver glaucoma care during the pandemic, as featured in the January/February 2021 issue of <em>Glaucoma Today.</em></p>]]>
      </content:encoded>
      <itunes:duration>624</itunes:duration>
      <guid isPermaLink="false"><![CDATA[11bc5bc8-90c2-11eb-a129-b375deb6d9ba]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7454636863.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Getting Started With #Ophthalmology</title>
      <description>Edmund Tsui, MD, an assistant professor of ophthalmology at the Stein Eye Institute at the David Geffen School of Medicine at UCLA, offers a primer on Twitter for ophthalmologists looking to get started with social media, as featured in the January/February 2021 issue of Glaucoma Today.</description>
      <pubDate>Mon, 01 Mar 2021 11:28:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Edmund Tsui, MD, an assistant professor of ophthalmology at the Stein Eye Institute at the David Geffen School of Medicine at UCLA, offers a primer on Twitter for ophthalmologists looking to get started with social media, as featured in the January/February 2021 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Edmund Tsui, MD, an assistant professor of ophthalmology at the Stein Eye Institute at the David Geffen School of Medicine at UCLA, offers a primer on Twitter for ophthalmologists looking to get started with social media, as featured in the January/February 2021 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>489</itunes:duration>
      <guid isPermaLink="false"><![CDATA[46d80b5e-7aab-11eb-8a41-fb420ca97384]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL9772743618.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>The Case for Gonioscopy</title>
      <description>Marez Megalla, MD, an ophthalmology fellow at the Yale School of Medicine, outlines the benefits of mastering gonioscopy during ophthalmology training, as featured in the November/December 2020 issue of Glaucoma Today.</description>
      <pubDate>Wed, 27 Jan 2021 14:41:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Marez Megalla, MD, an ophthalmology fellow at the Yale School of Medicine, outlines the benefits of mastering gonioscopy during ophthalmology training, as featured in the November/December 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Marez Megalla, MD, an ophthalmology fellow at the Yale School of Medicine, outlines the benefits of mastering gonioscopy during ophthalmology training, as featured in the November/December 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>481</itunes:duration>
      <guid isPermaLink="false"><![CDATA[dd1746d6-60d7-11eb-8d5c-e3f85a1971a1]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8489999004.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Newfound Insights Into Glaucoma Care </title>
      <description>In this episode, several physicians share how they have navigated the range of challenges presented by COVID-19 over the past year and how these challenges have yielded new discoveries about glaucoma and its management, as featured in the November/December 2020 issue of Glaucoma Today.</description>
      <pubDate>Tue, 12 Jan 2021 22:21:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this episode, several physicians share how they have navigated the range of challenges presented by COVID-19 over the past year and how these challenges have yielded new discoveries about glaucoma and its management, as featured in the November/December 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this episode, several physicians share how they have navigated the range of challenges presented by COVID-19 over the past year and how these challenges have yielded new discoveries about glaucoma and its management, as featured in the November/December 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>855</itunes:duration>
      <guid isPermaLink="false"><![CDATA[640e73e4-551b-11eb-ac3e-77a7bd03ae68]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2803755159.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Moving Glaucoma Surgery Into the Clinic</title>
      <description>Sébastien Gagné, MD, Director of the Institut de l’Oeil des Laurentides in Montreal, outlines the advantages of performing MIGS outside the OR, as featured in the November/December 2020 issue of Glaucoma Today.</description>
      <pubDate>Wed, 30 Dec 2020 13:14:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Sébastien Gagné, MD, Director of the Institut de l’Oeil des Laurentides in Montreal, outlines the advantages of performing MIGS outside the OR, as featured in the November/December 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Sébastien Gagné, MD, Director of the Institut de l’Oeil des Laurentides in Montreal, outlines the advantages of performing MIGS outside the OR, as featured in the November/December 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>541</itunes:duration>
      <guid isPermaLink="false"><![CDATA[122f0db8-4acb-11eb-8a60-7b24ed4c7c87]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4043047882.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>A New Era in Visual Field Testing</title>
      <description>Chris Johnson, PhD, DSc, Emeritus Professor of Ophthalmology and Visual Sciences at the University of Iowa Hospitals and Clinics in Iowa City, discusses technological advances in diagnostic testing, including tablet- and internet-based procedures and the use of virtual reality headsets, as featured in the November/December 2020 issue of Glaucoma Today.</description>
      <pubDate>Mon, 21 Dec 2020 11:18:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Chris Johnson, PhD, DSc, Emeritus Professor of Ophthalmology and Visual Sciences at the University of Iowa Hospitals and Clinics in Iowa City, discusses technological advances in diagnostic testing, including tablet- and internet-based procedures and the use of virtual reality headsets, as featured in the November/December 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Chris Johnson, PhD, DSc, Emeritus Professor of Ophthalmology and Visual Sciences at the University of Iowa Hospitals and Clinics in Iowa City, discusses technological advances in diagnostic testing, including tablet- and internet-based procedures and the use of virtual reality headsets, as featured in the November/December 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>778</itunes:duration>
      <guid isPermaLink="false"><![CDATA[674bacae-43a8-11eb-bf9e-a7c01b393f24]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL1564410058.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Drive-Through IOP Checks</title>
      <description>Gerami Seitzman, MD, Medical Director of the Francis I. Proctor Foundation at the University of California, San Francisco, shares how she and her colleagues developed a drive-through IOP screening service for patients whose care was interrupted by COVID-19, as featured in the September/October 2020 issue of Glaucoma Today.</description>
      <pubDate>Tue, 24 Nov 2020 17:05:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Gerami Seitzman, MD, Medical Director of the Francis I. Proctor Foundation at the University of California, San Francisco, shares how she and her colleagues developed a drive-through IOP screening service for patients whose care was interrupted by COVID-19, as featured in the September/October 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Gerami Seitzman, MD, Medical Director of the Francis I. Proctor Foundation at the University of California, San Francisco, shares how she and her colleagues developed a drive-through IOP screening service for patients whose care was interrupted by COVID-19, as featured in the September/October 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>561</itunes:duration>
      <guid isPermaLink="false"><![CDATA[38d9c53e-2ea1-11eb-ab65-2767ec347d34]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL6891089920.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Lights, Camera, Virtual!</title>
      <description>Lisa Nijm, MD, JD, Founder and Medical Director of Warrenville EyeCare and LASIK, in Warrenville, Illinois, shares her top 12 tips for elevating the quality of your online presentations, as featured in the September/October 2020 issue of Glaucoma Today.</description>
      <pubDate>Mon, 16 Nov 2020 15:26:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Lisa Nijm, MD, JD, Founder and Medical Director of Warrenville EyeCare and LASIK, in Warrenville, Illinois, shares her top 12 tips for elevating the quality of your online presentations, as featured in the September/October 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Lisa Nijm, MD, JD, Founder and Medical Director of Warrenville EyeCare and LASIK, in Warrenville, Illinois, shares her top 12 tips for elevating the quality of your online presentations, as featured in the September/October 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>727</itunes:duration>
      <guid isPermaLink="false"><![CDATA[4eb22a16-284a-11eb-83e7-a3fff87e2fc0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL7663469205.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Global Outreach in the Era of COVID-19</title>
      <description>Hunter Cherwek, MD, Vice President of Clinical Services with Orbis International, talks about the recent launch of Orbis International’s virtual Flying Eye Hospital training program for eye care providers around the globe, as featured in the September/October 2020 issue of Glaucoma Today.</description>
      <pubDate>Wed, 28 Oct 2020 17:42:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Hunter Cherwek, MD, Vice President of Clinical Services with Orbis International, talks about the recent launch of Orbis International’s virtual Flying Eye Hospital training program for eye care providers around the globe, as featured in the September/October 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Hunter Cherwek, MD, Vice President of Clinical Services with Orbis International, talks about the recent launch of Orbis International’s virtual Flying Eye Hospital training program for eye care providers around the globe, as featured in the September/October 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>612</itunes:duration>
      <guid isPermaLink="false"><![CDATA[5fa15464-1945-11eb-a898-4f5e00dc96e9]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3049130620.mp3?updated=1604063570" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Home-Based Glaucoma Monitoring</title>
      <description>Kateki Vinod, MD, discusses some of the existing and emerging tools for expanding glaucoma diagnosis and management beyond the office, as featured in the July/August 2020 issue of Glaucoma Today.</description>
      <pubDate>Wed, 14 Oct 2020 04:01:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Kateki Vinod, MD, discusses some of the existing and emerging tools for expanding glaucoma diagnosis and management beyond the office, as featured in the July/August 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Kateki Vinod, MD, discusses some of the existing and emerging tools for expanding glaucoma diagnosis and management beyond the office, as featured in the July/August 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>631</itunes:duration>
      <guid isPermaLink="false"><![CDATA[648867fe-0cb3-11eb-bfff-cfdec41d31d0]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL8288197223.mp3?updated=1603388935" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Intracameral Injection: Revisiting the Consensus</title>
      <description>In this special episode of GT: The Podcast, Drs. E. Randy Craven, Oluwatosin Smith, and I. Paul Singh expand upon the guidance presented in the “Evolving Guidelines for Intracameral Injection” paper by Jeffrey M. Liebmann, MD, et al, that was published in the Journal of Glaucoma in March 2020. This podcast episode is supported by Allergan Medical Affairs. </description>
      <pubDate>Wed, 07 Oct 2020 15:48:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>In this special episode of GT: The Podcast, Drs. E. Randy Craven, Oluwatosin Smith, and I. Paul Singh expand upon the guidance presented in the “Evolving Guidelines for Intracameral Injection” paper by Jeffrey M. Liebmann, MD, et al, that was published in the Journal of Glaucoma in March 2020. This podcast episode is supported by Allergan Medical Affairs. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>In this special episode of GT: The Podcast, Drs. E. Randy Craven, Oluwatosin Smith, and I. Paul Singh expand upon the guidance presented in the “Evolving Guidelines for Intracameral Injection” paper by Jeffrey M. Liebmann, MD, et al, that was published in the <em>Journal of Glaucoma</em> in March 2020. This podcast episode is supported by Allergan Medical Affairs. </p>]]>
      </content:encoded>
      <itunes:duration>1535</itunes:duration>
      <guid isPermaLink="false"><![CDATA[c3996bec-07f6-11eb-b3b2-6bbe74a90511]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL3040325569.mp3?updated=1674139367" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>A Disease of Paradoxes</title>
      <description>Amol Sura, MD, ophthalmology resident at the University of Alabama at Birmingham, reflects on the ups and downs of addressing glaucoma, as featured in the July/August 2020 issue of Glaucoma Today.</description>
      <pubDate>Mon, 28 Sep 2020 17:12:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Amol Sura, MD, ophthalmology resident at the University of Alabama at Birmingham, reflects on the ups and downs of addressing glaucoma, as featured in the July/August 2020 issue of Glaucoma Today.</itunes:summary>
      <content:encoded>
        <![CDATA[<p>Amol Sura, MD, ophthalmology resident at the University of Alabama at Birmingham, reflects on the ups and downs of addressing glaucoma, as featured in the July/August 2020 issue of <em>Glaucoma Today</em>.</p>]]>
      </content:encoded>
      <itunes:duration>474</itunes:duration>
      <guid isPermaLink="false"><![CDATA[63a35da6-01cf-11eb-a3ae-7b73e8401895]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL2287147766.mp3" length="0" type="audio/mpeg"/>
    </item>
    <item>
      <title>Cannabis and Glaucoma</title>
      <description>Ahmad Aref, MD, MBA, provides an update on the complex relationship between cannabis ingestion and glaucomatous optic neuropathy, as featured in the July/August 2020 issue of Glaucoma Today. </description>
      <pubDate>Tue, 18 Aug 2020 18:43:00 -0000</pubDate>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:season>1</itunes:season>
      <itunes:episode>1</itunes:episode>
      <itunes:author>Glaucoma Today </itunes:author>
      <itunes:subtitle></itunes:subtitle>
      <itunes:summary>Ahmad Aref, MD, MBA, provides an update on the complex relationship between cannabis ingestion and glaucomatous optic neuropathy, as featured in the July/August 2020 issue of Glaucoma Today. </itunes:summary>
      <content:encoded>
        <![CDATA[<p>Ahmad Aref, MD, MBA, provides an update on the complex relationship between cannabis ingestion and glaucomatous optic neuropathy, as featured in the July/August 2020 issue of <em>Glaucoma Today</em>. </p>]]>
      </content:encoded>
      <itunes:duration>545</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <guid isPermaLink="false"><![CDATA[e2a0f3c2-e17f-11ea-91b7-9f973cfd7f96]]></guid>
      <enclosure url="https://traffic.megaphone.fm/BMCL4429364314.mp3" length="0" type="audio/mpeg"/>
    </item>
  </channel>
</rss>
